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Abstract
EFFECT OF SUBSTRATE LIGAND PRESENTATION ON THE MOTILITY OF HUMAN T-LYMPHOCYTES
George Aaron Dominguez
Daniel A. Hammer
T lymphocyte homing and migration is critical for host defense and immunity. T lymphocytes must be
captured from blood flow, tether and roll on the endothelial surface, engage chemokine receptors, and
firmly adhere and migrate to sites of inflammation or to secondary lymphoid organs. How adhesive
ligands, soluble factors such as chemokines, and fluid shear flow influence the motility of T lymphocytes
is important for understanding this dynamic cascade of events. In this thesis, primary human T
lymphocyte motility was quantified on various adhesive ligands (haptokinesis) in the presence of
chemokines (chemokinesis) and in response to fluid flow. Through the use of microcontact printing onto
PDMS surfaces we created surfaces that presented ligand at controlled densities either alone or in
combination. The adhesive ligands ICAM-1, VCAM-1, and fibronectin were used to quantify cell migration
in the absence of chemokine revealing different modes of T lymphocyte motility with ICAM-1 having an
overall greater contribution. Using the homeostatic chemokines CCL19, CCL21, and CXCL12, we
demonstrated that motility is biphasic and is dependent upon ICAM-1 concentration, and by presenting
chemokines in combination, we can drive motility to higher levels than what was seen with each
chemokine individually. Finally we demonstrated that directed migration either upstream or downstream
of fluid flow is dependent upon the presence of ICAM-1, VCAM-1, or a combination of the two and the
shear rate used. We have been able to show that adhesive ligands, chemokines, and shear flow all work in
concert to promote robust primary human T lymphocyte adhesion and migration on microcontact printed
PDMS surfaces. This research further elucidates how T lymphocytes interpret these signals for
controlling homing to and motility within secondary lymphoid organs and the mechanisms of their
migration.
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ABSTRACT

EFFECT OF SUBSTRATE LIGAND PRESENTATION ON THE MOTILITY OF
HUMAN T-LYMPHOCYTES
George Aaron Dominguez
Daniel A. Hammer
T lymphocyte homing and migration is critical for host defense and immunity.

T

lymphocytes must be captured from blood flow, tether and roll on the endothelial surface,
engage chemokine receptors, and firmly adhere and migrate to sites of inflammation or to
secondary lymphoid organs. How adhesive ligands, soluble factors such as chemokines,
and fluid shear flow influence the motility of T lymphocytes is important for understanding
this dynamic cascade of events. In this thesis, primary human T lymphocyte motility was
quantified on various adhesive ligands (haptokinesis) in the presence of chemokines
(chemokinesis) and in response to fluid flow. Through the use of microcontact printing
onto PDMS surfaces we created surfaces that presented ligand at controlled densities either
alone or in combination. The adhesive ligands ICAM-1, VCAM-1, and fibronectin were
used to quantify cell migration in the absence of chemokine revealing different modes of
T lymphocyte motility with ICAM-1 having an overall greater contribution. Using the
homeostatic chemokines CCL19, CCL21, and CXCL12, we demonstrated that motility is
biphasic and is dependent upon ICAM-1 concentration, and by presenting chemokines in
combination, we can drive motility to higher levels than what was seen with each
chemokine individually. Finally we demonstrated that directed migration either upstream
or downstream of fluid flow is dependent upon the presence of ICAM-1, VCAM-1, or a
vi

combination of the two and the shear rate used. We have been able to show that adhesive
ligands, chemokines, and shear flow all work in concert to promote robust primary human
T lymphocyte adhesion and migration on microcontact printed PDMS surfaces. This
research further elucidates how T lymphocytes interpret these signals for controlling
homing to and motility within secondary lymphoid organs and the mechanisms of their
migration.
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CHAPTER 1: INTRODUCTION
“Though many lay unburied, birds and beasts would not touch them, or died after tasting
them…The bodies of dying men lay one upon the other…[But] those who had recovered
from the disease…had now no fear for themselves; for the same man was never attacked
twice - never at least fatally.”
Thucydides, History of the Peloponnesian War, 431-428 B.C.
MOTIVATION
The immune system relies upon the ability of leukocytes to home and migrate to
sites of inflammation or to tissues that facilitate further cell activation [1, 2].

T-

lymphocytes are a class of leukocytes that naturally circulate throughout the body in search
of antigen presenting cells (APCs) within secondary lymphoid organs (SLOs) that trigger
their activation. This behavior, known as immune surveillance, is controlled by various
adhesion ligands and chemokines that permit access to these SLOs [3]. In order for this to
occur, T-lymphocytes must exit blood flow, firmly adhere to the blood endothelium, resist
large hemodynamic forces, and migrate in response to gradients of adhesion ligands and/or
chemokines [4]. Defects in T lymphocyte function, motility, and homing can lead various
pathologies that impair immune function and health; therefore, it is critical to understand
how these factors contribute to T lymphocyte motility and what extent adhesive ligands,
chemokines, and fluid flow modulate them.
Integrins expressed on the T lymphocyte surface are critical for cell activation and
facilitating interactions with other leukocytes.
1

Particularly, Lymphocyte Function

Associated-antigen 1 (LFA-1) and Very Late Antigen-4 (VLA-4) are necessary to mediate
transient and firm adhesions for migration (haptokinesis) to the blood endothelium during
leukocyte extravasation [5].

Ligation of chemokine receptors with their cognate

chemokine(s) provides intracellular signals that increase integrin activation and drive
motility in response to a gradient (chemotaxis) or a local uniform concentration
(chemokinesis) [6, 7]. Furthermore, in order for T lymphocytes to migrate on the blood
endothelium, resistance to shear caused by fluid flow must be established via LFA-1- and
VLA-4-mediated interactions (mechanotaxis). Elucidating how these factors contribute to
T lymphocyte adhesion and motility is critical in understanding their function. Thus, the
objective of this thesis, as outlined in the specific aims below, is to determine how adhesive
ligands, chemokines, and shear flow work together in driving T lymphocyte adhesion and
motility.
Specific Aim 1a: Characterize the motility of primary human T-lymphocytes on
microcontact printed PDMS surfaces.
Integrin-ligand interactions are critical for T-lymphocyte trafficking and motility in the
body. In this aim, we quantify the haptokinetic responses of T-lymphocytes to ICAM-1
and VCAM-1 on microcontact printed (µCP) PDMS substrates. T-lymphocytes will be
seeded onto these integrin-binding proteins and their displacements will be tracked over
time to calculate the differences in the random motility coefficients as a function of ligand
composition and concentration. We hypothesize that biphasic motility will be observed
for both ligands.

2

Specific Aim 1b: Characterize the chemokinetic behavior of primary human Tlymphocytes in response to the homeostatic chemokines CCL19 and CCL21.
It is well known that CCL19 and CCL21 are required for T-lymphocyte homing to
secondary lymphoid organs (SLOs) through binding of the CCR7 chemokine receptor. In
this aim, we quantify the chemokinetic responses of T-lymphocytes to CCL19 and CCL21
individually and in a combinatorial fashion to further elucidate the motility observed within
SLOs. We hypothesize that there will be a peak in motility at a specific concentration of
chemokine that will be near the KD of the CCR7 receptor and, through combinatorial
chemokine signaling, we will observe synergistic effects in migration through dual CCR7
ligation.
Specific Aim 2: Quantify the motility of primary human T-lymphocytes on ICAM-1,
VCAM-1 and combined ICAM-1/VCAM-1 PDMS surfaces under shear flow.
During the homing of T lymphocytes to SLOs, cells must be captured from blood flow and
migrate before diapedesis through the blood endothelium. The hemodynamic forces
experienced by cells can be large and vary in magnitude throughout the body. In this aim,
we quantify the ability of T-lymphocytes to migrate on ICAM-1, VCAM-1, and combined
ICAM-1/VCAM-1 µCP PDMS surfaces as a function of shear rate and ligand density. We
expect T-lymphocytes to elicit different modes of migration specifically in the direction of
motility (mechanotaxis). Furthermore, it is also known that VCAM-1 engagement is
capable of increasing β2-dependent adhesion leading to changes migration. By presenting
cells with various combinations of both ICAM-1 and VCAM-1, a synergetic response in
adhesion should be observed further modulating directional migration under fluid flow
3

further elucidating the contributions of ICAM-1 and VCAM-1 to T-lymphocyte motility
specifically under fluid flow.
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CHAPTER 2: BACKGROUND
IMMUNITY
Immunity is the ability to avoid infection and disease through sufficient biological
defenses. This concept dates back to the 5th century BC when Thucydides wrote of
individuals who recovered from illness during the Plague of Athens but were then able to
nurse the sick without contracting it a second time. Along with Thucydides, scientists such
as Edward Jenner, Robert Koch and Louis Pasteur led to the evolution of a field of medicine
known as immunology. This is the study of the immune system and all the physical,
chemical, and physiological components involved in its formation and function.
The immune system can be further separated into two forms of distinct yet
interconnected kinds of immunity: innate and adaptive. At the heart of them are leukocytes
- cells that defend the body against pathogens and foreign material by eliciting their
immune functions. These dynamic and diverse groups of cells are capable of, but not
limited to, recognizing and engulfing foreign pathogens, eliciting an allergic reaction,
targeting cells for destruction, and providing immunity against a variety of diseases. These
functions are all critical for the ability of the cells to “get to where they need to be”; in
other words, they must migrate to their target sites rapidly, efficiently, and effectively.
Defects in this process lead to complications in the immune response and increase the risk
of death from infection.
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OVERVIEW OF T-LYMPHOCYTES
Beginnings of T-Lymphocyte Biology
Although the concept of immunity has been recognized for over 2500 years, it was
not until the early 1900’s that lymphocytes were first implicated in allograft rejection of a
foreign tissue. James Murphy recognized that tumor cells were difficult to inject and grow
in adult organisms but could be grown in chick embryos. Upon injection of adult lymphoid
tissue near the site of tumor cell implantation, rapid destruction of the cells occurred
illustrating protection and graft rejection [1-3]. In 1964, it was first demonstrated that small
lymphocytes continuously re-circulate from the thoracic duct, to blood, through secondary
lymphoid tissue, and back to the thoracic duct [4]. Jacques Francis Albert Pierre Miller
was the first to identify the essential role of the thymus in immune function and proposed
the existence of the two major subsets of lymphocytes in mammals: T and B [5-7]. In
1975, the phenotypic and functional separation of CD8+ and CD4+ cells was established
[8-10]. In the years that have past, we have seen a flurry of research and understanding in
T lymphocyte biology that has led to novel technologies and therapeutics used to improve
health and fight disease. Masopust et al. provides a thorough review of the history in the
discovery of T lymphocytes [11].
The Career of a T-Lymphocyte
T lymphocytes develop from progenitors that are derived from the pluripotent
hematopoietic stem cells in the bone marrow and migrate through the blood to the thymus,
where they mature; for this reason they are called thymus-dependent (T) lymphocytes.
Once cells leave the thymus, they are known as naïve and must determine whether antigen
present poses a threat to the body. This is achieved through interactions with dendritic
7

cells found in secondary lymphoid organs [8].

Encounter with an antigen induces

proliferation of T lymphocyte clones, yielding approximately 1000 times more descendants
having identical antigenic specificity. After acquiring effector functions, they home to sites
of inflammation where they interact with other leukocytes and parenchymal cells to elicit
their immune functions [9]. Most effector cells die after antigen clearance but some remain
for long-term protection against a re-exposure to antigen (TMEM). A variety of molecules,
such as integrins, adhesive ligands, and chemokines, are involved and work in concert to
promote proper T lymphocyte homing, migration, and activation [12].
LEUKOCYTE HOMING AND MIGRATION
Leukocyte Homing
A successful immune response is critically dependent on the ability of leukocytes
to leave blood circulation and enter the tissue space. This process involves a series of welldefined adhesive events involving primary adhesion molecules permitting the cell to be
captured from flow and slow down (tethering/rolling), exposure to a chemoattractant
stimulus through binding of a G-protein-coupled receptor, and then firm adhesion and
arrest mediated by increased integrin activation [12-16]. These steps are necessary for
migration and eventual leukocyte diapedesis through the blood endothelium permitting
access to sites of inflammation or entrance to lymphoid tissue. This process is illustrated
in Figure 2.1 and is known as leukocyte adhesion cascade and extravasation.
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Figure 2.1. Overview of the leukocyte adhesion cascade and extravasation. Cells are
captured from flow and undergo tethering/rolling via selectin molecules as well as
integrins. Upon chemokine activation, cells arrest and undergo adhesion strengthening to
support intravascular crawling and transmigration. Illustration redrawn from [16].
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T-lymphocytes in circulation are covered in short microvilli containing bundles of
actin filaments with low-affinity adhesion molecules such as L-selectin and the α4β1 (VLA4) integrin concentrated at the tips [17]. These molecules foster the tethering and rolling
events upon the blood endothelium. Other adhesion molecules are involved in firm
adhesion events, such as the αLβ2 (LFA-1) integrin, and are either distributed randomly on
the cell surface or completely excluded from the tips [18]. Upon chemokine engagement,
the microvilli collapse exposing firm adhesion molecules converting previous transient
rolling interactions into stable, firm adhesions thus supporting subsequent transmigration
through the endothelium [19].
T-Lymphocyte Motility
Leukocytes demonstrate rapid movement and flexibility in migrating through their
environment compared to slower moving cells such as fibroblasts and endothelial cells.
These frequent shape changes and dynamic cytoskeletal rearrangements have therefore led
to their mode of migration being described as amoeboid. It has been demonstrated that
some leukocytes migrate three-dimensionally through tissue without the need for integrins
while in two-dimensions they are required [20]. This has led to questions as to what are
the molecular requirements that promote leukocyte motility.
Migrating T-lymphocytes exhibit “hand mirror” morphology with a large cell body
comprised of the nucleus followed by a narrow trailing uropod which projects above the
surface [21]. Their mode of migration is driven by protrusion of actin-rich pseudopodia at
the leading edge with contractile forces at the rear all controlled by members of the Rho
GTPase famly of proteins, including RhoA, Rac1, and Cdc42 [22, 23]. Integrins mediate
adhesion through interactions with their ligands via signals transmitted from inside the cell
10

termed “inside-out” signaling in response to chemoattractant binding to Gi-protein-coupled
receptors. These signals elicit the transition from rolling to firm adhesion specifically
through increased avidity and affinity of integrins [8, 9].
T-Lymphocyte Integrins: LFA-1 and VLA-4
Integrins are heterodimeric, transmembrane receptors that consist of an α and β
chain linking the extracellular environment to the cell via adhesions ligands [24].
Adhesions are crucial for both the development and homeostasis of multicellular organisms
[25]. Within the immune system, integrins participate in leukocyte attachment to blood
endothelium and antigen presenting cells (APCs), cytotoxic killing, and extravasation of
cells into lymph nodes or target tissues. Integrins predominantly expressed by leukocytes
consist of a β2 subunit coupled with one of several α subunits (αLβ2, αMβ2), or the α4 subunit
with its β1 subunit counterpart (α4β1 and α4β7), and are capable of binding several adhesive
ligands (Figure 2.2).

Particularly, the integrins known as Lymphocyte Function-

Associated Antigen-1 (LFA-1; αLβ2) and Very Late Antigen-4 (VLA-4; α4β1) are critical
for T lymphocyte activation and for facilitating interactions with other leukocytes, such as
dendritic cells and B-lymphocytes, in order to elicit effector functions [12, 13, 26, 27]. In
this thesis, we will focus on LFA-1- and VLA-4-mediated adhesion and motility in
response to the engineered microenvironment.
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Figure 2.2. Leukocyte integrins and their ligands. Leukocyte integrins bind to liagnds
found on the vascular endothelium as well as to components of the extracellular matrix
(ECM). ICAM-1, intracellular adhesion molecule-1. ICAM-2, intracellular adhesion
molecule-2. VCAM-1, vascular adhesion molecule-1. CS-1, connecting segment-1 of
fibronectin. FN, fibronectin. VN, vitronectin. LN, laminin.
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LFA-1 is expressed exclusively by leukocytes and is known to be involved in
recruitment to inflammatory sites and lymphoid tissues as well as adhesions to other
leukocytes [13]. Patients with leukocyte adhesion deficiency (LAD) lack the β2 subunit
and thus the ability to clear pathogens leading to recurrent infections and death at an early
age. LFA-1 binds to a family of cell adhesion molecules known as intercellular adhesion
molecules (ICAMs) which include ICAM-1, ICAM-2, ICAM-3, ICAM-4, and ICAM-5
[28-32]. The principal adhesion molecules used for migration are ICAM-1 and ICAM-2
and are involved in regulating LFA-1 function through outside-in signaling. ICAM-1 is
expressed constitutively only at low levels on vascular endothelial cells and on some
leukocytes [33]. Increase in ICAM-1 expression on multiple cell types has been shown to
be induced by stimulation with inflammatory cytokines such as interleukin (IL)-1, tumor
necrosis factor (TNF) α, interferon (IFN) γ or with lipopolysaccharide (LPS) [34-36].
Interactions between LFA-1 and ICAM-1 is accomplished through binding of the D1
domain of ICAM-1’s five immunoglobulin (Ig)-like domains and requires LFA-1
activation [37].. The affinity and avidity of LFA-1 can be regulated through inside-out
signaling, as well, by upstream regulators such as Rap-1 [38]. Calcium and diacylglycerolregulated guanine nucleotide exchange factor I (CalDAG-GEFI) regulates Rap-1 activity
and is known to be directly involved in LFA-1 activation induced by chemokines and PMA
activation [39, 40]. Regulator of adhesion and polarization enrich in lymphocytes (RAPL),
an effector molecule associated with Rap-1, is also involved in integrin activation triggered
through chemokine engagement promoting LFA-1 dependent adhesion [41, 42].
VLA-4 is expressed by most resting lymphocytes, eosinophils, and monocytes, and
plays a role in the development and differentiation of several tissue and cell types [43-45].
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VLA-4 is expressed by bone marrow CD34+ hematopoietic stem cells and is required for
mobilization and homing of peripheral blood progenitors [93]. VLA-4 is capable of
binding to fibronectin through the connecting segment-1 (CS-1) domain and to vascular
cell adhesion molecule-1 (VCAM-1). This integrin is vital for competent immune function
and has a tightly regulated multi-step function during rolling and arrest of leukocytes on
the endothelium [46, 47]. VLA-4 is also involved in formation of the immunological
synapse and cytoskeletal adaptor molecules, such as Rap-1, paxillin, and talin, regulate the
adhesiveness [48]. As with LFA-1, Rap-1 also participates in the inside-out triggering of
increased VLA-4 activation allowing for ligand binding and cell adhesion [49]. VLA-4 is
known to be implicated in numerous autoimmune diseases and chronic inflammation such
as multiple sclerosis, Crohn’s disease, asthma, stroke, rheumatoid arthritis, and
inflammatory bowel disease and is commonly a target for therapeutics of these diseases
[50-55].
VLA-4’s principal ligand, VCAM-1, contains 7 Ig-like domains and has been
shown to be expressed in lymph nodes and the bone marrow to be used for the regulation
of leukocyte homing [56]. Within the lymph nodes, VCAM-1 is expressed by postcapillary
high endothelial venule (HEV) cells and follicular dendritic cells with increased expression
induced by cytokines, high levels of reactive oxygen species (ROS), oxidized low density
lipoprotein (oxLDL), high glucose, and turbulent shear stress [57]. Unlike LFA-1/ICAM1 interactions, VLA-4 is capable of binding to two different domains (D1 or D4) depending
upon the level of integrin activation; low affinity VLA-4 readily binds to the D1 domain
of VCAM-1 while increased integrin activation is required for binding to the D4 domain
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[58]. Thus, the binding of T lymphocytes to VCAM-1 domains is regulated by the
activation state of VLA-4.
These integrins are critical for recruitment of leukocytes into sites of inflammation
and lymphoid tissues through interactions with the blood endothelium under shear flow. It
is known that cells respond to mechanical forces and are able to sense shear flow
deformation (mechanoresponsive) [59].

Other cells types are known to respond to

mechanical forces such as endothelial cells which align themselves along the direction of
fluid flow [60, 61]. Under flow, VLA-4 participates in transient adhesion events, such as
tethering and rolling, allowing for the capture of T-lymphocytes from fluid flow leading to
firm arrest on VCAM-1 [46, 47]. Shear flow is known to stabilize and strengthen adhesion
contacts mediated through LFA-1 and VLA-4 interactions [62-65]. These firm adhesions
have been shown to be mandatory for T-lymphocyte migration on the endothelium and
transendothelial migration (TEM) [66-69].
In this thesis, all T-lymphocytes were activated using phytohemagglutinin-M
(PHA-M) leading to T-cell receptor (TCR) stimulation [70]. It has also been shown that
upon activation, expression levels of LFA-1 and VLA-4 do not change but the activation
level does increase to support cognate ligand binding [24, 71, 72]. Under such activation,
T-lymphocytes migrate on adhesive ligand without chemokine, which we employ in this
work.
T-Lymphocyte Polarity and Motility
In order for T-lymphocytes to respond to cues from the environment, cells must
polarize and organize their intracellular machinery required for migration.

This

polarization is generally considered in terms of two distinct regions: the “front” and the
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“rear.” The front leading edge, or lamellipodium, is an F-actin rich region of the cell that
is broad and flat driving the cell forward through actin polymerization and formation of
new adhesions to the substratum independent of myosin II crosslinking [73, 74].
Projections from the lamellipodium, known as filopodia, are thin, finger-like protrusions
that assist in leading edge attachment and migration. The real trailing edge, or uropod, is
generally characterized by the retraction of old adhesions from the substratum and is much
smaller than its leading edge counterpart. These two regions of the cell are believed to be
governed by distinct signaling molecules and pathways. Molecules typically found near
the leading edge of a migrating cell are PI3K, Rac, Cdc42, and most molecules associated
with actin polymerization such as ARP 2/3 and WASP [75-77]. WASP has also been found
to be required for optimal chemotaxis in vitro and in vivo [78-80]. Within the rear of the
cell, molecules such as PTEN, Rho, ROCK, and myosin II are found contributing to
actomyosin contraction allowing for cell forward propulsion [81].

Since Rho is

downstream of chemokine GPCRs and is required for increased integrin affinity, it is
believed that Rho is located near the site of GPCR signaling that then activates ROCK to
result in actomyosin contraction necessary to generate forward thrust (Figure 2.3) [82-84].
Although the molecular players in polarity and migration have been identified, there is still
much debate about the precise combination of molecules and signaling pathways that
govern overall migration [85].
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Figure 2.3. Adherent contractile zone found in migrating T lymphocytes along the cell
and substratum interface. Rho may be used downstream from chemokine receptors and
integrins to activate ROCK promoting myosin II contractility. MLC, myosin light chain.
CAM, cell adhesion molecule. Illustration redrawn from [84].
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Amoeboid Cell Motility
Although many molecules and signaling pathways such as PI3K, Rac, Cdc42, and
Rho are conserved across numerous cell types, there are important distinctions to be made
between amoeboid and mesenchymal migration. Amoeboid migration can be considered
as a primitive mode of cell migration as even prokaryotes and lower level eukaryotes are
able to display this mode of fast migration.

Unlike cells displaying mesenchymal

migration, these cells to do not use long-lasting, highly stable focal adhesions and typically
lack stress fibers. This is not surprising seeing as these cells are highly dynamic and must
be able to manipulate their body shape and cytoskeleton to alter their migration paths. They
are capable of squeezing through small spaces such as tight junctions and pores within
three-dimensional matrices where cells displaying mesenchymal migration typically
require extracellular matrix remodeling through proteolysis and matrix metalloprotease
(MMP) activity.
Classical models of amoeboid migration are typically done in the slime-mold
Dictyostelium discoideum [77, 86, 87] and fish keratocytes [88, 89]. The most classic and
heavily studied model for amoeboid motility in immune cells has been neutrophils [90, 91],
and most recently, dendritic cells [92-95].
Dynamics of Migration
The coordinated motion of a cell plays a key role in development, angiogenesis,
wound healing, cancer metastasis, immunity, and many other physiological processes.
Often times, this motion is directed by external cues such as adhesion molecules (e.g.
ICAM-1, VCAM-1), attractants (e.g. chemokines) and/or mechanical force (e.g. shear
flow). Coordinated cell movement and migration is generally believed to have a purpose
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(such as in the immune response) thus irregularities in this dynamic process can lead to
pathologies [96, 97]. The random motility of cells can be used to quantify the conditions
necessary to efficiently perform a search to locate randomly distributed target items such
as a pathogen or antigen presenting cell.
A normal cell’s trajectory resembles those of normal Brownian particles and is
characterized by the mean-squared displacement, MSD, defined as
𝑀𝑆𝐷(𝑡) = 〈[𝑥(𝑡 + 𝑡0 ) − 𝑥(𝑡0 )]2 + [𝑦(𝑡 + 𝑡0 ) − 𝑦(𝑡0 )]2 〉
where 〈… 〉 denotes the combined average over all starting times 𝑡0 and cell paths for a
population [98].

Random walk theories have long been used to model animal

displacements such as foraging behavior, predator-prey relationships, etc.; furthermore,
these theories have also been used to model mammalian cell migration as uncorrelated
random walks assuming that cells maintain no memory of previously taken steps [99, 100].
In theory, cells will move ‘nowhere’ on average, and their expected mean-squared
displacement is linear with time. This is often used to convey the difference between a
random walk versus directed motion such as chemotaxis where the root mean-squared
displacement is linear with time [101]. Random walk is also known as Brownian motion
which can be characterized by a mean-squared displacement proportional to ~tα for long
time (t) intervals with α = 1 indicating random diffusion. Anomalous diffusion arises when
α ≠ 1 with subdiffusive behavior observed when α < 1, superdiffusive with α > 1, and
ballistic motion when α = 2. Recent evidence has demonstrated that Madin-Darby canine
kidney (MDCK) cells, mammary epithelial cells (MCF-10A), human neutrophils, and D.
discoideum move spontaneously in random directions and exhibit superdiffusive motion
[90, 102-104]. Work shown in Harris et al. discusses that murine CD8+ T lymphocytes
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undergo Lévy walks (a form of superdiffusive motion) to control the pathogen Toxoplasma
gondii [105]. They propose that this type of motion occurs in order to increase the
frequency of finding rare targets with more than an order of magnitude increase in
efficiency compared to Brownian motion walkers by covering more territory. This strategy
is used by a number of animals including monkeys and marine life to increase foraging
efficiency [106-108].

In contrast, Miller et al. demonstrated that naïve murine T-

lymphocytes undergo random walks within SLOs [109].

Here, in this thesis, we

characterize the motility of activated human T-lymphocytes in vitro on engineered surfaces
presenting ICAM-1 and VCAM-1

CHEMOTACTIC CYTOKINES (CHEMOKINES)
Chemokine Signaling
Lymphocytes express a variety of chemokine receptors (CCRs) that allow them to
navigate throughout the body. The unique combination of CCRs expressed on a cell is
thought to provide direction toward, retention within, and egress from a specific organ. As
previously noted, T-lymphocytes are capable of binding to CCL19 and CCL21 via the
CCR7 receptor as well as CXCL12 via the CXCR4 receptor which are required for entry
into SLOs.
Chemokines themselves are small (approximately 8 – 14 kDa) and structurally
related chemotactic cytokines that direct cell migration for a variety of leukocytes via their
cognate binding interactions with G-protein coupled receptors (GPCRs) [110, 111].
Chemokines can be subdivided into 4 distinct groups (CXC, CX3C, CC, and C) according
to the positioning of the first two closely paired and highly conserved cysteines of the
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amino acid sequence [112]. Currently, over 40 chemokines are known in the human
genome, most having homologues in mice. The main cell types directed by chemokines
are neutrophils, dendritic cells, monocytes, macrophages, and lymphocytes, all of which
have a role in host defense. In addition to providing directional cues, it has been suggested
that chemokines also play fundamental roles in the development, homeostasis, and function
of the immune system [110, 111, 113]. Furthermore, chemokines are also used outside of
the immune system in a variety of cell types, including cells of the central nervous system
or endothelial cells, where they can produce either angiogenic or angiostatic effects [114,
115]. This thesis will focus on the chemokines involved in the homing of T lymphocytes
to SLOs specifically CCL19 and CCL21 with a less emphasis on CXCL12.
Chemokine receptors are a family of 7-transmembrane GPCRs found
predominantly on leukocytes [112, 116]. Chemokine receptors are generally composed of
approximately 350 amino acids, and have conserved structural motifs. The N-terminus
generally has a short section of acidic residues oriented into the extracellular space binding
to specific chemokines. The seven helical transmembrane domains orient into a barrel
shape butted by three intracellular and three extracellular hydrophilic loops; the
intracellular C-terminus contains hydroxyl groups (serine and threonine) providing sites
for phosphorylation which in turn regulate receptor signaling [116]. Although chemokine
receptors bear significant homology in their primary sequences, they typically bind only a
small number of ligands, often only a single one. The chemokine receptor is named for the
subtype of chemokine it binds, and is numbered according to an agreed-upon standard
[110]. Our focus is on the CCR7 and, to a lesser extent, CXCR4 receptors for our
investigation into T-lymphocyte adhesion and chemokinesis.
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Chemokines and T-lymphocytes
CCR7 is a typical member of the 7-transmembrane domain GPCR family. Its two
known ligands CCL19 and CCL21 exhibit similar affinities for receptor binding (~10 nM)
[92, 117]. Signaling is thought to proceed by activation of a G-protein of the Gαi subfamily
which may or may not be precoupled to the receptor. CCR7 binds the α-subunit of the Gprotein and releases the βγ-subunit potentially activating both for downstream signaling.
It has not been established which of CCR7's effects are downstream of the α and βγ subunits
though preliminary evidence points to PI3K activity downstream of the βγ subunit [118].
Following activation,

GPCRs

eventually become desensitized

and ultimately

downregulated through a series of events occurring near the cytoplasmic carboxyl
terminus. In one of the few studies of CCR7 phosphorylation, CCL19 was shown to induce
significantly more phosphorylation than CCL21 in a human T cell lymphoma cell line [119,
120]. Once the GPCR is phosphorylated, arrestins are recruited to then induce clathrinmediated endocytosis. CCL19 has been shown to induce a lower steady-state level of
CCR7 surface expression by higher rates of endocytosis in a human T cell lymphoma cell
line [120]. Also, it has been shown that CCL19 is able to desensitize a T lymphocyte’s
responsiveness to CCL21, but not vice versa [117]. In vivo, this may allow cells to respond
first to CCL21 expressed on afferent lymphatic vessels, then subsequently to CCL19 to
drive homing and migration to SLOs [121-123]. Cumulatively, significant evidence
suggests that although CCL19 and CCL21 have similar affinities for CCR7, their
downstream regulation has the potential to activate distinct physiological responses.
Furthermore, deletion of CCR7 or its ligands, CCL19 and CCL21, in the plt/plt
mouse does not fully impair dendritic cell migration to lymph nodes (although it is

22

abnormal), implying that the process is complex and that additional chemokine-receptor
pairs are likely to be involved. Within this same model, T lymphocytes show a delayed
yet still intact immune response that is markedly prolonged [124]. For T lymphocytes, it
is known that these chemokines are required for homing to the lymph node although the
relative contributions of CCR7/CCL21 and CXCR4/CXCL12 signaling to T lymphocyte
migration are not well studied. Recent research has shown that dendritic cells respond
CCL19, CCL21, and CXCL12 differently during chemotaxis [92]. Other studies have
shown that T lymphocytes are capable of chemotaxing to CCL19 and CCL21 in a
microfluidic device eliciting different responses to chemokine concentration [125, 126].
In one study, the effects of the two chemokines were shown to not be additive [127].
Although these chemokine–receptor pairs may function independently of one another,
combinatorial signaling is most likely required for effective homing and migration. These
ideas are investigated in this thesis in the context of CCR7-mediated chemokinesis.
RECEPTOR-LIGAND KINETICS FOR CHEMOKINESIS
Monovalent Ligands Binding to a Monovalent Receptor
Receptor-ligand kinetics can be used to describe how a chemokine interacts with
its cognate receptor, and thus, how the cells respond to that chemokine in solution. For
equilibrium binding for the simple reversible reaction scheme between a monovalent free
receptor R and a monovalent free ligand L to form a receptor/ligand complex C, the
reaction can be written as
𝑅+𝐿 ↔ 𝐶
where the relevant rate constants are the association rate constant k𝑓 and the dissociation
rate constant k 𝑟 . We can solve for the time rate of change for receptor/ligand complex C
23

as a function of free receptor number R and the ligand concentration L using principles of
mass action kinetics described as
𝑑𝐶
= 𝑘𝑓 𝑅𝐿 − 𝑘𝑟 𝐶
𝑑𝑡
𝑑𝐶

Assuming steady state conditions ( 𝑑𝑡 = 0), the receptor-ligand binding kinetic equation
can be solved as
𝐶=

𝑅𝐿
𝐾𝐷

𝑘

where 𝐾𝐷 = 𝑘𝑟 which is known as the equilibrium dissociation constant. A small value of
𝑓

𝐾𝐷 indicates a high affinity of the receptor for the ligand; the avidin/biotin bond is one of
the highest affinity bonds in nature with a 𝐾𝐷 = 10−15 𝑀 [128]. If we then assume that
ligand concentration is constant, we can solve for receptor/ligand complexes at
equilibrium, 𝐶𝑒𝑞 , and is described as

𝐶𝑒𝑞 =

𝑅𝑇 𝐿
𝐾𝐷 + 𝐿

where 𝑅𝑇 is the total number of receptors on the cell surface [98].
Differential Receptor Occupancy and the 𝑲𝑫 : The Driving Force for Chemokinesis
The theory of differential receptor occupancy tells us that there is an ideal number
of bound receptor complexes in a system that can achieve ideal chemokinesis [129]. If
[𝐿] ≪ 𝐾𝐷 then 𝐶𝑒𝑞 ≈ 0 and the cell will not be able to sense the presence of the chemokine.
On the contrary, if [𝐿] ≫ 𝐾𝐷 then 𝐶𝑒𝑞 ≈ 𝑅𝑇 meaning all available receptors are occupied
preventing the cell from sensing the chemokine. When the concentration of chemokine is
near the 𝐾𝐷 then 𝐶𝑒𝑞 ≈ 0.5𝑅𝑇 and only half the receptors are bound. This provides enough
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ligand around the cell to engage the receptors allowing for intracellular signaling to drive
chemokines and/or chemotaxis.
The random motility coefficient for cells undergoing migration in a uniform field
of chemokine (chemokinesis) has been shown to induce migration in a typical bell-shaped
does-response curve with increasing chemokine concentration [92, 130]. This means that
the random motility coefficient will increase with chemokine concentration until a peak is
reached followed by a decline. For chemotaxis studies, values of the mean concentration
near the 𝐾𝐷 of the receptor are known to enhance directed migration [92, 131, 132].
These principles have been applied to experimentally determine the concentration
of chemokine to support optimal migration of cells in both chemokinesis and chemotaxis
assays; for instance, recent evidence has shown that CCR7 expressed by dendritic cells
have a 𝐾𝐷 ranging between 1 to 10 nM which is near the 𝐾𝐷 previously observed for
CCL19/CCL21/CCR7 interactions [92, 117]. Since T-lymphocytes express the same
receptor, CCR7, it is of interest to determine if T lymphocytes respond in the same way as
dendritic cells or if the same chemokine-receptor interactions govern their motility
differently.

LITHOGRAPHY FOR CELL MIGRATION
PDMS
Polydimethylsiloxane (PDMS) is part of a family of organic silicon polymers referred to
as silicones. PDMS is the most widely used silicone for biological applications, and its
rheological properties allow it to be cast against three-dimensional structures whose
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features are permanently maintained after curing. PDMS is ideal for microscopy because
it is optically clear and is stiff enough to withstand large amounts of pressure permitting it
to be used for microfluidics [133]. The shear modulus of PDMS is also easily varied from
~100 kPa to ~10 MPa by varying the ratio of elastomer to curing agent [134].
While PDMS is not fully biocompatible, it is inert, non-toxic, and non-flammable.
After curing, the PDMS is both hydrophobic and methyl-terminated. The predominant –
Si surface chemistry makes it difficult for polar solvents like water to wet the surface; this
makes it attractive for binding hydrophobic compounds such as proteins. Plasma or UV
ozone treatments can be used to oxidize the surface creating silanol (Si – OH) groups which
increase its affinity for binding hydrophobic compounds. The oxidized surfaces are only
stable for approximately 30 minutes due to hydrophobic recovery.
Overall, PDMS is an ideal candidate to be used for microcontact printing (µCP)
due to (1) it can be readily made to generate micron-scale features on a substrate of a large
area, (2) PDMS has low surface energy allowing to be separated from the template during
fabrication and after stamping, and (3) it is relatively inert so it does not react with many
chemicals [135].
Photolithography and Soft Lithography
Photolithography was developed in the 1950’s and involves patterns of arbitrary
complexity to be etched into very flat surfaces. A thin layer of photoresist is deposited on
a flat silicon wafer via spin-coating. The desired pattern is then created in the photoresist
by shining collimated light though a high resolution photomask. There are two types of
photoresist; negative photoresists cure when exposed to light while positive photoresists
degrade upon exposure to light [136]. Once a master is created, a negative replica can be
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cast with PDMS by pouring degassed PDMS over the master and then curing at 25 – 150
ºC to fully crosslink the polymer. Soft lithography builds upon this and was invented by
George Whitesides in the late 1990’s using photomasks, polymer-based stamps and molds
in various combinations to fabricate or replicate patterns [137]. There are two main steps
involved. First, the fabrication of a pattern onto a substrate creating a ‘master’, and second,
the use of that pattern to produce features negatively defined by the pattern’s relief structure
in an elastomeric substrate. The master is created using photolithography on silicon
substrates. The term “soft” comes from the use of elastomeric materials, especially PDMS.
This platform is commonly used to create features on the micron scale but can be scaled
down to the nanometer scale [138, 139].
Microcontact Printing
Most classical adhesion and motility assays involve preparing two-dimensional
surfaces by adsorbing an adhesive ligand onto glass or polystyrene with subsequent
blocking with a solution of bovine serum albumin (BSA). The BSA is meant to block bare
regions of the substrate that would otherwise encourage non-specific cell-substrate
interactions. It has been demonstrated that some leukocytes are capable of interacting with
BSA-blocked surfaces; specifically, it has been shown that human neutrophils bind to BSA
through the use of the integrin Mac-1 (αMβ2) [90]. Microcontact printing allows for the
creation of surfaces that do not support these type of non-specific interactions. Over the
past decade, interests have increased in further understanding of the cell and how it
interacts with its external environment. There have been rapid advances in the ability to
engineer surfaces with geometrically patterned regions of adhesive ligand surround by non-
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adhesive regions to provide insight into how the structure of the cell, surrounding
extracellular matrix, and cell-cell interactions drive specific cell functions [140-143].
Methods to pattern adhesive ligand has proliferated greatly over the past decade
[144]. The most commonly used technique is known as microcontact printing which was
originally developed by George Whitesides and colleagues over two decades ago [137].
For this technique, flat PDMS stamps are used to transfer “inked” material onto a substrate.
This technique has been used to pattern PDMS spin-coated substrates with various
geometric patterns of ligand [142, 143].
The use of microcontact printing is extensively employed in this work to create
surfaces that present adhesive ligand with or without chemokine in order to study the
haptokinesis and chemokinesis of human primary T-lymphocytes.

Furthermore, we

demonstrate that these surfaces can be combined with a parallel flow chamber assay to
investigate how shear flow dictates their migration in response to varying shear rates or
ligand concentrations.
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CHAPTER

3:

T

CELL

HAPTOKINESIS

AND

CHEMOKINESIS

ON

MICROCONTACT PRINTED PDMS SUBSTRATES
Adapted from: Dominguez GA and DA Hammer. “Effect of adhesion and chemokine
presentation on T-lymphocyte haptokinesis.” Integrative Biology. 2014, 6 (9), 862 – 873.
ABSTRACT
Motility is critical for the function of T-lymphocytes. Motility in T-lymphocytes
is driven by the occupancy of chemokine receptors by chemokines, and modulated by
adhesive interactions. However, it is not well understood how the combination of adhesion
and chemokine binding affects T-lymphocyte migration. We used microcontact printing
on polymeric substrates to measure how T lymphocyte migration is quantitatively
controlled by adhesion and chemokine ligation. Focusing only on random motion, we
found that T-lymphocytes exhibit biphasic motility in response to the substrate
concentration of either ICAM-1 or VCAM-1, and generally display more active motion on
ICAM-1 surfaces. Furthermore, we examined how the combination of the homeostatic
chemokines CCL19 and CCL21 contribute to motility. By themselves, CCL19 and
CCL21, ligands for CCR7, elicit biphasic motility, but their combination synergistically
increases CCR7 mediated chemokinesis on ICAM-1. By presenting CCL21 with ICAM1 on the surface with soluble CCL19, we observed random motion that is greater than what
is observed with soluble chemokines alone. These data suggest that ICAM-1 has a greater
contribution to motility than VCAM-1 and that both adhesive interactions and chemokine
ligation work in concert to control T-lymphocyte motility.
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INTRODUCTION
Recruitment of T lymphocytes into lymphoid organs and peripheral tissues during
immune surveillance and inflammation is critical for their function. T lymphocytes make
use of the integrins Lymphocyte Function Associated Antigen-1 (LFA-1; αLβ2) and Very
Late Antigen-4 (VLA-4; α4β1) in cell trafficking, TCR formation and maturation, cell-tocell binding, and motility within secondary lymphoid organs (SLOs) and tissues [1-4].
Within SLOs, T lymphocytes are exposed to adhesion ligands and chemokines that
coordinate interactions between T lymphocytes and antigen presenting cells [5-8]. In vivo
it is thought that in order for T lymphocytes to reach their destination, migrating cells must
sense a gradient of soluble or surface immobilized chemokine(s) released from a distant
source providing them with a chemotactic cue for directed migration [6, 9]. Within the
SLO, homeostatic chemokines such as CCL19 and CCL21 are thought to play a key role
in controlling migration and regulating the dynamics of motility by binding to the CCR7
receptor. It has been shown in vitro that T cells undergo chemotaxis in response to CCL19
and CCL21 within microfluidic devices [10]. However, the role that adhesion molecules
play in regulating the response to chemokines is under appreciated.
Although it is commonly thought that directional migration in chemokine gradients
is needed for lymphocyte positioning in the SLOs, it is possible that chemokinesis plays a
strong role in lymphocyte exploration within the SLOs. There is no convincing evidence
for directional trafficking of T lymphocytes under steady-state conditions as observed
within explanted lymph nodes, but adhesive ligands and chemokines expressed by
fibroblastic reticular cells have been shown to guide migration within the lymph nodes to
facilitate T-lymphocyte activation [10-16]. It has been shown in vivo that T cells are
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capable of migrating at speeds up to 40 µm/min with frequent changes in direction [11].
At uniform concentrations, chemokines are capable of modulating cell speeds, and the
observed random migration of T lymphocytes observed within lymph nodes may be due to
a chemokinetic response to near-uniform levels of chemokines in the tissue [5, 17].
Additionally, binding of these chemokines to their Gi-protein-coupled receptor, CCR7, are
capable of altering motility by modulating integrin activity through inside-out signaling
pathways that indirectly modulate T cell homing to SLOs [5, 18, 19]. Recent work has
elucidated the importance of how chemokines coordinate with adhesive ligands to support
adhesion and migration, but the exact interplay between the two is still not fully understood
[5, 20-22].
Presentation of the ligands Intracellular Adhesion Molecule-1 (ICAM-1) and
Vascular Cell Adhesion Molecule-1 (VCAM-1) to their corresponding cognate receptors
LFA-1 and VLA-4 in the absence of chemokine is capable of inducing polarization critical
for adhesion and motility via reorganization of the actin and microtubule cytoskeletons [19,
23-25]. Studies have shown that CCL21 is capable of synergizing with adhesion ligands
to increase adhesion, speed, and random motility in vitro [5]. However, to our knowledge,
there has not been a quantitative analysis of the contributions of ICAM-1 and VCAM-1 on
random motility in the absence of chemokines (haptokinesis) and the effect of varying
chemokine concentrations (chemokinesis).
For this chapter, we measured the motility of primary human T lymphocytes on
different densities of the cell adhesion molecules ICAM-1 and VCAM-1 on microcontact
printed PDMS substrates. This technology allows for the precise control of the density and
type of adhesion molecule present on the surface; for example, we recently used
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microcontact printing to show how different densities of fibronectin can elicit a phenotypic
switch in neutrophil motility [26]. Specifically, we investigated how the random motility
of T lymphocytes is controlled by varying concentrations of adhesion ligands, first in the
absence and then in the presence of chemokine. We found that T lymphocytes exhibit
biphasic motility when either ICAM-1 or VCAM-1 is presented alone in the absence of
chemokine, with an overall greater motility on ICAM-1 substrates than VCAM-1. Then,
we measured the effects of CCL19 and CCL21 on the motility of T lymphocytes and how
combinations of the two chemokines modulate their motility. We found that individually,
CCL19 and CCL21 also elicit similar biphasic motility with a peak in the random motility
coefficient near an intermediate concentration of chemokine, and when combined,
synergize to increase random motility. Furthermore, this synergistic effect is maintained
when CCL21 is presented on the surface with soluble CCL19 on ICAM-1 surfaces. These
results provide insight to how adhesive ligands and chemokines control the random
migration of T lymphocytes in the absence of chemokine gradients.
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MATERIALS AND METHODS
Cell culture and reagents
Human blood was obtained via venipuncture from healthy adult donors and
collected into sterile tubes containing sodium heparin (BD Biosciences, San Jose, CA).
Samples were collected with University of Pennsylvania Institutional Review Board
approval from consenting adult volunteers. Blood samples were carefully layered in a 1:1
ratio of whole blood to 1-Step™ Polymorphprep (Axis-Shield, Oslo, Norway). Vials were
then centrifuged at 1500 rpm for 35 minutes and the mononuclear band was collected into
a fresh vial. Figure 3.1 depicts resulting buffy coat after centrifugation and band isolated
for culture. Cells were cultured in RPMI-1640 supplemented with 10% FBS and 1 μg/ml
of phytohemagglutinin-M (PHA-M; Sigma-Aldrich, St. Louis, MO) overnight. After 24
hours, the lymphocyte suspension in the PHA medium was transferred into a new flask
leaving behind adherent cells. After an additional 48 hours, the cells were then cultured in
RPMI-1640 with 10% FBS and 1% penicillin-streptomycin supplemented with 20 ng/ml
of interleukin-2 (IL-2; Roche, Mannheim, Germany). Cells were used for experimentation
following an additional 72 hours in culture. Flow cytometry was employed to verify
population of T-lymphocytes through identifying cells labeled with FITC conjugated antiCD3+ (clone OKT3) (Affymetrix eBioscience, San Diego, CA) and population was
determined to be 98.69% CD3+ (Figure 3.2). Other biological reagents included: protein
A/G (Thermo Scientific, Rockford, IL), human ICAM-1/Fc and VCAM-1/Fc (R&D
Systems, Minneapolis, MN), human IgG1 (Abcam, Kendall Square, MA), human anti-αL
(clone 38) and human anti-β2 (clone IB4) (Calbiochem, San Diego, CA), human anti-αM
(Clone M1/70.15.1) (Millipore, Temecula, CA), human anti-β1 (clone Mab13) and rat
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isotype IgG2a (BD Pharmingen, San Jose, CA), human CCL19/CCL21 (PreproTech,
Rocky Hill, NJ), Pluronics F127 (Sigma-Aldrich, St. Louis, MO), Alexa 568-labeled
phalloidin and Alexa488-labeled mouse anti-α tubulin (Invitrogen, Grand Island, NY).
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Figure 3.1. Separation of whole blood for cell isolation. Image of resulting buffy coat
after centrifiguation of whole blood layered over 1-Step™ Polymorphprep. The layer
containing platelets, monocytes, and lymphocytes was collected.
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Cell Count

Cell Count

Figure 3.2. Flow cytometry results of T-lymphocytes to verify CD3+ population. (A)
Plot of side scatter versus forward scatter of population of cells isolated from whole blood
after 7 days of activation and culture. Heat map shows majority of cells to be mostly
mononuclear indicating population of T-lymphocytes. (B) Isotype control and (C) antiCD3 FITC antibody labeling showing high number of CD3+ positive cells in tested
population after culturing. Population was determined to be 98.69% CD3+. These are
representative plots from one of three separate experiments.
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Substrate preparation
Poly(dimethylsiloxane) (PDMS) (Sylgard 184 Silicone Elastomer, Dow Corning,
Midland, MI) coated coverslips were prepared from number one thickness glass coverslips
(Fisher Scientific, Hampton, NH) of 25 mm diameter spin coated with degassed PDMS
(10:1 base:cure by weight) and cured overnight at 65 ºC. PDMS-coated coverslips were
affixed to the bottom of six-well tissue culture plates which has been laser-cut to generate
a 22 mm diameter opening in the bottom of the wells. Coverslip bonding was performed
using a small amount of PDMS (10:1 base:cure by weight) and baked at 65 ºC for 30
minutes for curing.
Protein printing and blocking
Flat stamps for printing were prepared by pouring degassed PDMS mixed at 10:1
base:cure by weight over an unpatterned silicon wafer. The polymer was cured for 2 hours
or longer at 65 ºC. Stamps were trimmed, sonicated in 200 proof ethanol for 10 minutes,
rinsed with dH2O, and dried in a stream of N2(g). For motility studies, stamps were 1 cm2
and were inked with 200 µl of 2 µg/ml of protein A/G in PBS for 2 hours at room
temperature. The stamps were then thoroughly rinsed in H2O and blown dry with a stream
of N2. In parallel, the six-well PDMS coverslip substrate was treated with ultraviolet ozone
for 7 minutes (UVO Cleaner Model 342, Jelight Company, Irvine, CA) to render the
surface hydrophilic. The stamp was then placed in conformal contact with the substrate
for ~10 seconds and removed. A 0.2% (w/v) solution of Pluronics F127 was immediately
adsorbed to the PDMS substrates for 30 minutes at room temperature to prevent protein
adsorption to non-functionalized portions of the PDMS. The cell culture substrate was
then rinsed with PBS 3X without dewetting the functionalized surface before deposition of
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200 µl of either ICAM-1/Fc or VCAM-1/Fc in PBS for 2 hours at room temperature. The
surfaces were then rinsed with PBS 3X without dewetting before incubation with cells. We
tested whether saturation points of ICAM-1/Fc were different upon physisorption to glass
or printed onto PDMS. Using Alexa Fluor-555 conjugated Protein A/G, we prepared
substrates for adhesion that were either glass and blocked with 1% BSA in PBS or stamped
onto PDMS and blocked with 0.2% F127 Pluronics. Figure 3.3 demonstrates that there is
increased non-specific adhesion of T lymphocytes to glass substrates; PDMS substrates
appear to have more uniformity in ligand deposition as indicated by a more uniform signal
in fluorescence.
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Figure 3.3. Physisorption and printing of fluorescent protein A/G. Scale bar = 100 µm;
10X magnification
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ELISA to determine protein deposition on PDMS substrates
For substrate preparation, 45X50 mm glass coverslips (No. 1, Fisher Scientific
Pittsburgh PA) were spin coated with PDMS and cured as described previously. Flat
stamps were inked with Protein A/G solution as described previously followed by coverslip
activation and printing. Coverslips (PDMS spin coated or glass) were then adhered via
PDMS to the bottom of a 24 well plate whose bottoms had been cut out. 0.2% F-127
Pluronics solutions was deposited into each well for 30 minutes at room temperature. Each
well was then rinsed with PBS 3X followed by deposition of 200 µl of ICAM-1/Fc protein
solution into each well for 2 hours at room temperature. For the glass substrates, protein
A/G was physisorbed to the surface for 2 hours at room temperature followed by surface
blocking with 5% milk in PBS solution for 1 hour at room temperature. After wells were
rinsed with PBS 3X, solutions of ICAM-1/Fc were deposited into each well for 2 hours at
room temperature followed by rinses of PBS 3X. A dilution of 1:5000 of polyclonal antihuman ICAM1 antibody (Biotin) (ab7815, Abcam, Cambridge, MA) in PBS + 1% BSA
and 200 µl was deposited into each well for one hour at room temperature. The plate was
washed with PBS + 1% BSA 3X to remove excess primary antibody and 200 µl of 1:5000
HRP-avidin in PBS + 1% BSA was deposited into each well. The plate was then washed
3X with PBS + 1% BSA to remove excess secondary antibody followed by ensuring that
the wells were completely dry.
400 µl of 1-Step™ Turbo TMB-ELISA reagent (Pierce Biotechnology), per well of
a 24 well plate was added to each well, to visualize the amount of HRP on each substrate.
The plate was incubated in the dark, at room temperature, for 15 minutes, to allow for the
reaction to occur. The reagent will turn blue in the presence of HRP and the reaction is

56

quenched with the addition of 400 µl of 2N H2SO4. Quenching the reaction changes the
color of the liquid in each well from blue to yellow. Finally, the ELISA was quantified by
measuring the absorbance of the liquid in each well at 450 nm on the Tecan Infinite 200
PRO plate reader (Tecan Group Ltd., Switzerland) to determine the amount of HRP in each
well. This colorimetric assay was then used to qualitatively asses the amount of ICAM1/Fc present on each substrate and each conditions was done in triplicate on two separate
occasions.
As shown in Figure 3.4, absorbance increases as the ICAM-1 concentration
increases in solution indicating differences in protein presentation across the
concentrations tested on both glass and PDMS substrates. All values are normalized by
the background absorbance from the control wells with zero ICAM-1/Fc present. Since
protein A/G is used and only capable of binding 6 Fc-chimera molecules at a time, we
assume these results apply to surfaces with VCAM-1/Fc ligand as well [27].
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Figure 3.4. Results of an HRP ELISA for ICAM-1. Results show that varying bulk
ICAM-1/Fc concentration incubated on protein A/G printed PDMS substrates results in
varying concentration of protein adsorbed to the surface. Averages were calculated from
replicates of three with error bars representing the standard error of the mean (s.e.m.).
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Haptokinesis and chemokinesis assay
PDMS substrates were prepared as described above. For printed CCL21 studies,
20 nM of CCL21 was inked with Protein A/G followed by stamping onto PDMS substrates.
Before use, all substrates were washed 3X with phosphate-buffered saline. Each well was
plated at 5 x 105 cells/ml in serum-free RPMI-1640 supplemented with 0.1% BSA and 2
mg/ml glucose. The substrate was then placed in a 37°C humidified atmosphere containing
5% CO2 in air incubator for 15 minutes to allow for cell attachment. The wells were then
gently washed 3X with PBS to remove non-adherent cells followed by imaging in a 5%
CO2 and 37°C environment for at least 1 hour. Cells were placed into a motorized stage
and observed using a Nikon Eclipse TE300 phase contrast microscope. A 10X objective
was used to capture images during the course of the time lapse. For chemokinesis assays,
a CCL19 and/or CCL21 chemokine solution was dispensed into each well before imaging
and performed on ICAM-1 substrates at a concentration of 0.05 µg/ml. For surface
presentation of CCL21, stamps were inked with 2 µg/ml of Protein A/G and 250 ng/ml of
CCL21 and printed onto the PDMS substrates before blocking and application of the Fc
protein solution.
Measurement of cell trajectories and mean-squared displacements
Cell movement was tracked using the ImageJ plugin Manual Tracking. ImageJ and
the plugin are both freely available through the NIH website (http://rsbweb.nih.gov/ij/).
The centroid of the cell was considered to represent the cell position. Time lapse
microscopy was used and images were taken every 1.5 minutes. The result was a series of
(x,y) positions with time for each cell. The net displacement during the 𝑖th 1.5 minute
increment, 𝐷𝑖 , was calculated by the difference of the position at the beginning and end of
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that time step. The mean-squared displacement, 〈𝐷2 (𝑡)〉, over time was calculated using
the method of non-overlapping intervals [28]. Speed, S, can be considered as the total path
length over time and persistence time, P, is the time a cell remains moving without
changing direction. S and P were obtained by fitting these to the persistent random walk
equation (Dunn, 1983 〈𝐷2 (𝑡)〉 = 2𝑆 2 [𝑡 − 𝑃(1 − 𝑒 −𝑡⁄𝑃 )] where t is the time interval, using
a non-linear least squares regression analysis [29, 30]. The mean-free path length (PL) and
random motility coefficient (µ) are then calculated as 𝑃𝐿 = 𝑃𝑆 and µ =

1
2

𝑆 2 𝑃 [31, 32].

Antibody Blocking
Functional blocking antibodies against the β1 integrin subunit (clone Mab13), β2
integrin subunit (clone IB4), αL integrin subunit (clone 38), and IgG2a isotype control
(clone R35-95) were used at a final concentration of 50 µg/ml. 5 x 105 T-lymphocytes in
500 µl of running buffer were incubated for 30 minutes with the blocking antibodies at
37ºC and 5% CO2. Cells were then plated and allowed to adhere for 15 minutes followed
by rinsing with PBS 3X and subsequent imaging in media containing blocking antibody.
Immunofluorescence
Primary human T lymphocytes were plated on 5.0 µg/ml ICAM-1/Fc and VCAM1/Fc surfaces with or without 250 ng/ml of stamped CCL21 at 5 x 105 cells/ml for 1 h in a
37°C humidified atmosphere containing 5% CO2. The cells were then fixed with 4%
paraformaldehyde in PBS for 7 minutes. Cells were permeabilized with 0.2% Triton X100 for 5 minutes and blocked with 1% BSA in PBS for 30 minutes at room temperature.
Cells were incubated with 1:200 Alexa 568-labeled phalloidin and Alexa 488-labeled
mouse anti-α tubulin (Invitrogen) for 30 minutes at room temperature. Cells were mounted
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in Fluoromount-G mounting medium (SouthernBiotech, Birmingham, Alabama) and
examined by confocal microscopy (Leica SP5).
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RESULTS AND DISCUSSION
Microcontact printing of Protein A/G and T lymphocyte adhesion
Protein A/G is a molecule produced through the fusion of the Fc-binding domains
of Protein A and Protein G. Use of this molecule in conjunction with Fc-chimera ligands,
such as ICAM-1/Fc and VCAM-1/Fc, has proven effective to immobilize chimeric proteins
bearing the Fc domain [27]. We used microcontact printing of Protein A/G to prepare
surfaces with controlled ratios of adhesion ligands linked to the Fc chimeras while keeping
total protein concentration constant. This is achieved by varying the ratios of ICAM-1/Fc
and VCAM-1/Fc molecules and human IgG1. The steps for microcontact printing for our
experimental system are illustrated in Figure 3.5.
Primary human T lymphocytes do not polarize and migrate on microcontact printed
Protein A/G alone or on Protein A/G surfaces incubated with human IgG1 as indicated by
a rounded morphology (Fig. 3.6A). Figure 3.6B demonstrates the fidelity of microcontact
printing and the binding selectivity of primary human T lymphocytes to ICAM-1/Fc
surfaces.
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Figure 3.5. Microcontact printing of PDMS substrates. Illustration for microcontact
printing of protein A/G followed by subsequent binding of either ICAM-1/Fc or VCAM1/Fc with IgG1.
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Figure 3.6. T lymphocytes adhere to microcontact printed PDMS substrates. (A) Phase
contrast images showing rounded morphologies for T lymphocytes indicating no polarity
and adhesion to Protein A/G or human IgG1 alone. Scale bars, 100 µm (B) Phase contrast,
fluorescence, and overlay images showing the fidelity of microcontact printed protein A/GAlex Fluor 555 conjugate on PDMS surfaces and binding selectivity of T lymphocytes to
ICAM-1/Fc. Scale bars, 100 µm.
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Either ICAM-1 and VCAM-1 alone trigger T lymphocyte haptokinesis
Primary human T lymphocytes adhere and migrate on PDMS surfaces printed with
ICAM-1 and VCAM-1. We measured haptokinesis on these ligands by quantifying the
mean-squared displacements over a range of ligand concentrations in the absence of
chemokine. From the mean-squared displacements over time, we could determine the
speed, persistence time, and random motility coefficient for each condition. T lymphocytes
plated on ICAM-1 or VCAM-1 surfaces were tracked for 30 minutes. As illustrated by
representative single-cell migration tracks (Fig. 3.7), T lymphocytes migrated substantial
distances on both 0.5 and 5.0 µg/ml of ICAM-1 or VCAM-1 with no preferred direction.
This remained true for all other concentrations of ligand tested.

65

Figure 3.7. T lymphocytes are more migratory on ICAM-1 than VCAM-1. Representative
single-cell migration tracks for T lymphocytes on 0.5 and 5.0 µg/ml of ICAM-1 and
VCAM-1 showing no preferred direction in migration.
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It is known that through LFA-1 (αLβ2) and VLA-4 (α4β1) integrin interactions T
lymphocytes are capable of migrating on ICAM-1 and VCAM-1 surfaces, respectively; we
verified this through functional integrin blocking (Fig. 3.8, A and B). Blocking of the α L
and β2 integrin chains resulted in a significant decrease in cell adhesion on ICAM-1 relative
to the positive control without antibody present (p < 0.01) (Fig. 3.8C). By targeting the β1
integrin, a significant decrease in cell adhesion on VCAM-1 relative to the positive control
without antibody present was observed (p < 0.01) (Fig. 3.8C). These data led us to attribute
the observed ICAM-1 and VCAM-1-induced adhesion and resulting motility to the specific
ligation of αLβ2 and α4β1 with their cognate ligands on these microcontact printed surfaces.
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A

B

C

D

Figure 3.8. Antibody blocking against LFA-1 and VLA-4 reveal discrete integrin/ligand
interactions on printed PDMS surfaces. (A) Phase contrast images of T lymphocytes
blocked against β1or αLβ2 integrins on ICAM-1 surfaces. (B) Phase contrast images of T
lymphocytes blocked against β1or αLβ2 integrins on VCAM-1 surfaces. Quantification of
antibody blocking against (C) αLβ2 and (D) β1 integrins show decreased cell adhesion to
ICAM-1 and VCAM-1 substrates, respectively; *p < 0.05, compared to isotype; onesample t test, error bars represent standard error of the mean (s.e.m.).
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Using the mean-squared displacements (MSD), we found that migrating T
lymphocytes on ICAM-1 surfaces traveled greater distances than on VCAM-1 surfaces as
suggested by larger MSDs with increasing time for all concentrations (Fig. 3.9, A and B).
This demonstrates that the dynamics of T lymphocyte motility on ICAM-1 and VCAM-1
are distinct. The use of random walk theories is common to quantify mammalian cell
migration. The MSDs of migration can be scaled as x 2(t) ∝ tα during 0 < t < 90 minutes
where fitting can be used to determine the exponent α to classify the type of motion for
each type and concentration of ligand. Random or Brownian motion is observed for the
value of α = 1 and ballistic motion is observed for α = 2, while values between the two are
categorized as superdiffusive motion. Cells migrating on ICAM-1 surfaces display an
average α over all concentrations of 1.57, indicating that T lymphocytes on ICAM-1
migrate superdiffusively through LFA-1 mediated interactions. Similarly on VCAM-1, T
lymphocytes display superdiffusive motion with an average α of 1.38 (Fig. 3.9C). Table
3.1 shows all values of fitted α’s for all concentrations of ligand tested. This data is
consistent with the recent observation that neither effector CD8+ T cells in vivo nor
neutrophils on microcontact printed fibronectin PDMS surfaces display pure diffusive
motion [26, 33].
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Figure 3.9. The mean-squared displacements versus time are linear on ICAM-1 and
VCAM-1. (A) MSD versus time showing linear trends on all concentrations of ICAM-1
tested. (B) MSD versus time showing linear trends on all concentrations of VCAM-1
2
α
tested. MSD can be scaled as x (t) ∝ t indicating that T lymphocytes acquire displacement
superdiffusively (α > 1) on representative concentrations of (C) ICAM-1 and (D) VCAM1 surfaces. Numbers on line represent approximate values of α over all concentrations of
ligand tested.
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Table 3.1. Average fitted α ± standard deviation on ICAM-1 and VCAM-1 surfaces.
Values of fitted α’s indicate superdiffusive for almost all concentration conditions on
ICAM-1 and VCAM-1 surfaces.
By scaling the mean squared displacements to tα and plotting them as slopes over
time, we see that all T lymphocyte motility lies between a slope of 1 (pure diffusion motion)
and a slope of 2 (pure ballistic motion) lying in the superdiffusive region (Fig. 3.10). This
is the first indication, to our knowledge, that T lymphocytes exhibit superdiffusive motion
on ICAM-1 and VCAM-1 ligands in vitro.
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Figure 3.10. Fitted mean-squared displacements versus time on ICAM-1 and VCAM-1
surfaces. The slopes of lines indicate the α’s determined by scaling the MSD previously
to tα. Red lines are values on ICAM-1 surfaces and blue lines are values on VCAM-1
surfaces. Slopes of the lines fall between values of 1 (pure diffusive motion) and 2 (pure
ballistic motion).
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To further characterize the motility of T cells on ICAM-1 and VCAM-1 surfaces,
we used the experimental mean-squared displacements of each cell population with the
persistent random walk model to fit for speed and persistence time. T lymphocytes were
shown to have larger cell speeds on varying concentrations of ICAM-1 when compared to
VCAM-1 (Fig. 3.11A); migrating T lymphocytes had average peak speeds (S) of 11.9 ±
1.12 µm/min and 4.3 ± 0.83 µm/min on 1.0 µg/ml of ICAM-1 and VCAM-1, respectively.
These values correspond to observations of speed as seen previously in vivo and in vitro
by other groups [9, 13, 14, 34, 35]. Persistence times (P) ranged from 1.9 ± 0.3 to 5.1 ±
0.7 minutes on ICAM-1 and 4.5 ± 0.7 to 8.9 ± 0.6 minutes on VCAM-1 (Fig. 3.11B). In
our system, higher cell speeds were observed on ICAM-1 compared to VCAM-1 (SICAM-1
> SVCAM-1) while generally cells were more persistent on VCAM-1 than ICAM-1 (PICAM-1
< PVCAM-1). Previous empirical observations have showed that speed and persistence times
are inversely correlated across a variety of cells types with high speeds correlating to short
persistence times and vice versa [36]. By plotting the speeds and persistence times across
all concentrations of ICAM-1 and VCAM-1, we observed that this inverse correlation holds
true for primary human T lymphocytes with a coefficient of determination (R2) of 0.7699
(Fig. 3.11C). Overall, on ICAM-1 surfaces, T- lymphocytes have higher speeds with lower
persistence times (↑ SICAM-1, ↓ PICAM-1) and on VCAM-1 surfaces, T lymphocytes have
lower speeds with higher persistence times (↓ SVCAM-1, ↑ PVCAM-1). These data suggests
that each ligand stimulates different adhesion signaling pathways.
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Figure 3.11. T lymphocytes elicit biphasic responses in speed and an inverse correlation
with persistence time on ICAM-1 and VCAM-1. T lymphocyte (A) speeds and (B)
persistence times determined from using the persistent random walk model; cells have
faster speeds and shorter persistence times on ICAM-1 with lower speeds and longer
persistence times on VCAM-1. (C) Across all concentrations of ligand an inverse
correlation is maintained between persistence time and cell speed. The error bars represent
the standard error of the mean (s.e.m.).
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The random motility coefficient (µ) is a metric that is commonly used to quantify
migration in response to ligands or cytokines in a population of cells and is the product of
the average cell speed (S) and mean-free path length (SP) divided by the dimensionality of
the system; therefore, it depends on the square of the speed and the first power of the
persistence time. Figure 3.12 demonstrates that the random motility coefficient increases
with increasing concentration of either ligand before reaching a maximum and then
decreases; in other words, the behavior is biphasic. On ICAM-1, the highest random
motility coefficient (µICAM-1) is 160 µm2/min, observed over a range of ICAM-1
concentrations between 0.5 to 10.0 µg/ml. T lymphocytes display a maximum µVCAM-1 of
103 ± 16.1 µm2/min at 0.5 µg/ml VCAM-1. The biphasic response of random motility
with ligand density has been observed in other systems, and is often explained by the ratio
of cell-substratum adhesiveness to cell contractility that would promote the highest level
of motility [37-39]. Overall, we found that cells exhibit greater motility on ICAM-1 than
VCAM-1 (µICAM-1 > µVCAM-1) for all concentrations tested.
Our data demonstrates that primary human T lymphocytes adhere and migrate
differently on ICAM-1 and VCAM-1 microcontact printed PDMS substrates. It is known
that T lymphocytes are capable of robust migration on ICAM-1 surfaces in the absence of
chemokine predominantly driven by outside-in signaling triggering full LFA-1 activation
[40, 41]. VLA-4, on the other hand, has been classically known to require chemokine
engagement to achieve full integrin activation and induce cell polarization; this may
explain why we observed decreased motility on VCAM-1 in the absence of chemokine
albeit the cells were previously activated. In Hyun et al., cells were similarly isolated and
activated in the same manner as we did yet they did not observe competent cell migration
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on VCAM-1 surfaces alone in the absence of chemokine [42]. Furthermore, experiments
conducted in Stachowiak et al. showed that unactivated (or naïve) murine T-lymphocytes
are not motile on adhesive ligand alone (ICAM-1, VCAM-1, fibronectin) and require
chemokine to exhibit robust migration [5]. In the next section, we further expand upon the
requirements of chemokine engagement to induce polarization and migration of human Tlymphocytes on ICAM-1 and VCAM-1 surfaces.
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Figure 3.12. Response in the random motility coefficient for all ligand concentrations on
ICAM-1 and VCAM-1 surfaces is biphasic. Comparison of the random motility
coefficients (µ) show biphasic motility as a function of ligand concentration with ICAM-1
2
(peak µICAM-1 = 172.77 ± 45.45 µm /min) promoting increased haptokinesis than VCAM2

1 (peak µVCAM-1 = 103.58 ± 16.06 µm /min). The error bars represent the standard error of
the mean (s.e.m.).
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Phenotypes of motility on the two ligands
Cell polarization and motility require the dynamic rearrangement of the actin and
microtubule cytoskeletons through signaling pathways involving the Rho family GTPases
[43-45].

For T lymphocytes, lamellipodium extension requires Rac-induced actin

polymerization while uropod detachment is mediated through Rho-ROCK signaling and
actomyosin contractility [40, 46, 47]. Studies have also demonstrated that chemokines
regulate integrin adhesive activity by modulating avidity and affinity and induce distinct
polarized cell morphology [48-50].
In order to investigate the mechanisms of motility of T lymphocytes on ICAM-1
and VCAM-1, we plated cells on 5.0 µg/ml of either ICAM-1 or VCAM-1. We found no
difference in cell area between ICAM-1 (189.6 ± 36.3 µm2; n = 281) and VCAM-1 (173.4
± 55.9 µm2; n = 127), (Fig. 3.13A). After plating T lymphocytes on 5.0 µg/ml of ICAM1 and VCAM-1, we fixed and permeabilized the cells, and fluorescently labeled their actin
and microtubule cytoskeletons. Based upon our observations, we observed the following
T lymphocyte phenotypes (Fig. 3.13C):


Polarized, Motile – cells which migrated several cell diameters with a polarized
morphology involving a clearly identifiable lamellipod, cell body, and uropod;



Polarized, Tethered – lymphocytes with a polarized morphology but tethered and
unable to move;



Non-polarized, Motile – migrating several cell diameters with protrusions but lacking
a clear polarized morphology;



Non-polarized, Non-motile – spherical cells which do not have protrusions and are not
migrating.
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ICAM-1 surfaces induce increased lamellipod formation and greater cell adhesion when
compared to VCAM-1 surfaces (Fig. 3.13B, left column). There are higher percentages of
polarized and motile T lymphocytes on ICAM-1 than VCAM-1 surfaces (37% versus 12%;
Fig. 3.13D and 3.13E). Also, ICAM-1 surfaces have fewer non-polarized and non-motile
lymphocytes compared to VCAM-1 surfaces (23% versus 69%).
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Figure 3.13. T lymphocytes are more polarized on ICAM-1 than VCAM-1. (A)
2
Measurements found no difference in cell area for ICAM-1 (189.6 ± 36.3 µm ; n = 281 )
2
versus VCAM-1 (173.4 ± 55.9 µm ; n = 127 ) (B) Fluorescence images showing T
lymphocytes on either ICAM-1 or VCAM-1 with or without hCCL21 on the surface. T
lymphocytes visibly exhibit greater polarity (lamellipod, cell body, and uropod) on ICAM1 surfaces with or without hCCL21 (top row) than compared to VCAM-1 surfaces (bottom
row). Cells were stained with Alexa568 phalloidin (red) and Alexa488 anti-α-tubulin
antibody (green). Scale bars, 10 µm. (C) Phase contrast and fluorescence images of the
four classifications for T lymphocyte migration: polarized and motile, polarized and
tethered, non-polarized and motile, and non-polarized and non-motile. (D) T lymphocytes
were classified based upon their migratory phenotype on ICAM-1 (n = 281) with or without
hCCL21. Around 37% of cells plated exhibited a polarized, motile phenotype. There was
no observable differences with the addition of hCCL21 (n = 127). (E) On VCAM-1 (n =
244) surfaces, cells are less polarized and motile (12% of cells) and the addition of hCCL21
(n = 267 for VCAM-1 increases the number of polarized, motile lymphocytes while
decreasing the number of non-polarized, non-motile cells on VCAM-1; *p < 0.05,
compared to no CCL21; one-sample t test.
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Effect of chemokines on T-lymphocyte motility
It is known that chemokines are capable of modulating T lymphocyte migration by
promoting integrin activation and Rho GTPase signaling and synergize with adhesion
ligands to alter adhesion, polarity, and motility [5]. The chemokine CCL21 is known to
adhere to surfaces and affect leukocyte motion [22, 51, 52]. We investigated whether
printing the chemokine CCL21 would increase the number of polarized and motile
lymphocytes in tandem with either ICAM-1 or VCAM-1. We found that hCCL21 does not
significantly change lamellipod formation of T lymphocytes on ICAM-1 (n = 244; Fig.
3.13B, top row) while it increases lamellipod formation on VCAM-1 surfaces (n = 267;
Fig. 3.13B, bottom row). The fraction of polarized and motile lymphocytes on ICAM-1
with or without hCCL21 did not change (37% versus 40%; Fig. 3.13D). However, hCCL21
increased the fraction of polarized and migratory cells significantly on VCAM-1 surfaces
(12% versus 22%) leading to a decrease in the percentage of non-polarized and non-motile
cells (69% versus 52%; Fig. 3.13E) (p < 0.05).
Our data demonstrates that T lymphocytes are capable of spontaneous adhesion and
migration to ICAM-1 and VCAM-1 surfaces in the absence of chemokine. We also
demonstrated that by the addition of CCL21 to the surface, T lymphocytes significantly
increase cell polarity and migration on VCAM-1 but not on ICAM-1 surfaces.
CCL19 and CCL21 individually induce T lymphocyte chemokinesis that is dependent
on ICAM-1 concentration
The chemokines CCL19 and CCL21 bind to the CCR7 receptor and are capable of
driving chemokinesis and chemotaxis [53-56]. Previous studies have predominantly used
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transwell assays to demonstrate chemokinesis and chemotaxis, but these three dimensional
assays provided limited ability to directly observe cells [20, 21, 57]. After having
determined the effect of ligand composition and densities on the motility of primary human
T lymphocytes, we investigated how soluble CCL19 (sCCL19) and CCL21 (sCCL21)
drive CCR7-mediated chemokinesis on ICAM-1 microcontact printed PDMS surfaces and,
specifically, how ligand concentration plays a role in the cell’s ability to respond to
chemokine concentration. We designated ICAM-1 concentrations of 5.0 µg/ml as high and
0.05 µg/ml as low; these two concentrations support spontaneous and robust T lymphocyte
migration, as shown above. We measured the random motility coefficient for a range of
CCL19 and CCL21 chemokine concentrations on both high and low concentrations of
ICAM-1. We observed no significant differences in the random motility coefficients as a
function of chemokine concentration on the high ICAM-1 surface with random motility
coefficients (µHIGH) ranging between 164 ± 14.4 to 226 ± 40.6 µm2/min (Fig. 3.14A). We
have shown that T lymphocytes are capable of sustained motility on ICAM-1 alone without
the need for chemokines, leading us to believe that sustained signaling through LFA1/ICAM-1 interactions at this high ligand concentration was overwhelming the signals that
resulted from CCR7 receptor engagement (outside-in versus inside-out signaling). On the
low ICAM-1 surface, we observed a biphasic response in motility to chemokine
concentrations. Statistically significant peaks in the random motility coefficients (µ LOW)
were observed at 20 nM for both sCCL19 (114.83 ± 4.76 µm2/min) and sCCL21 (109.37
± 8.77 µm2/min) when compared to the random motility coefficient observed on low
ICAM-1 alone (p < 0.05; Fig. 3.14A; Fig. 3.15). Empirical observations in other cell
systems, such as in murine dendritic cells, have estimated the KD of the CCR7 receptor to
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be near 10 nM, which is close to the value of 20 nM that corresponds to our observed peaks
in the random motility coefficients for both CCR7 ligands [58, 59]. Furthermore, Fig.
3.14B shows that T cell persistence times and speeds change with the addition of
chemokines while still maintaining an inverse correlation as seen in the absence of
chemokine. Almost all chemokine concentrations led to decreased speeds with increased
persistence times except at our maximum motility coefficient seen at sCCL21 and sCCL19
= 20 nM which had increased speeds and shorter persistence times (Fig. 3.14B; right panel).
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Figure 3.14. sCCL19 and sCCL21 individually induce chemokinesis on low ICAM-1
surfaces. (A) Comparison of the random motility coefficients (µ) for sCCL19 and sCCL21
show biphasic motility on low but not high ICAM-1 surfaces. Peak in chemokinesis
observed at 20 nM (µCCL19 = 174.13 ± 4.76 µm2/min and µCCL21 = 146.52 ± 8.77 µm2/min);
*p < 0.05, compared to all concentrations; one-sample t test. (B) T lymphocyte speeds
and persistence times during chemokinesis for sCCL19 and sCCL21 (left two panels); cells
maintain near same speeds and persistence times for each concentration of chemokine. The
right graph shows that across all concentrations of chemokine an inverse correlation is
maintained between persistence time and cell speed with an increased speed and decreased
persistence time for 20 nM. The error bars represent the standard error of the mean (s.e.m.).

84

A

20 nM sCCL19

B

20 nM sCCL21

Figure 3.15. Cell traces for sCCL19 and sCCL21 chemokinesis. Single cell migration
tracks showing random motility at (A) 20 nM CCL19 and (B) 20 nM CCL21 with no
preferred direction in migration.
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Combinatorial chemokine signaling on ICAM-1 surfaces increases chemokinesis
We have demonstrated that varying ligand concentration (haptokinesis) and
chemokine concentration (chemokinesis) can affect T lymphocyte motility. We next
examined how T lymphocyte motility can be modulated by combining soluble CCL19 and
CCL21 together, which both bind to the CCR7 receptor. Previous studies have shown that
these ligands elicit different responses upon binding to CCR7 owing to receptor
internalization and desensitization and signal attenuation [55, 60-62]. It has also been
shown that murine dendritic cells and human T lymphocytes are capable of differential
responses during chemotaxis to gradients of CCL19 and CCL21 [10, 59]. It is thought that
within the lymph node, T lymphocytes encounter antigen presenting cells, such as dendritic
cells, through random, autonomous motility within chemokine fields [11]. This led us to
believe that by exposing primary human T lymphocytes to varying uniform fields of both
sCCL19 and sCCL21, we would observe a difference in motility than what was seen with
sCCL19 or sCCL21 alone. Interestingly, we found that the chemokines act together to
increase motility greater than what was observed with the chemokines individually. A
peak in motility was observed when T lymphocytes were exposed to 1 nM of both sCCL19
and sCCL21 with a random motility coefficient of 203.00 ± 11.45 µm2/min (Fig. 3.16, Fig.
3.17B). For all equivalent concentrations of chemokines tested, the effect is superadditive
producing random motility coefficients that are greater than the sum of the values observed
individually with each chemokine except for the 20 nM condition. Our previous data has
shown that for 100 nM and 200 nM of sCCL19 and sCCL21 individually, the motility
coefficients are much lower than the maximum observed random motility coefficients
found at 20 nM for each chemokine. Surprisingly, when 100 nM sCCL19 and 100 nM
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sCCL21 were combined, the random motility coefficient increased significantly implying
a synergistic effect (172.87 ± 16.12 µm2/min). Furthermore, this effect was also observed
when 200 nM sCCL19 and 200 nM sCCL21 were combined (146.23 ± 36.45 µm 2/min).
The combination of both 20 nM of sCCL19 and sCCL21 produced no significant changes
in the motility coefficient when compared to that of the chemokines individually, with a
random motility coefficient of 129.28 ± 4.82 µm2/min. We then tested the effects of
combining a high concentration of one chemokine with another that is near where observed
peaks with chemokines alone. For cells exposed to 20 nM of sCCL19 and 200 nM of
sCCL21, we observed a random motility coefficient that is between what was observed on
the two surfaces alone, 148.71 ± 12.41 µm2/min. Furthermore, when we exposed cells to
200 nM of sCCL19 and 20 nM of sCCL21, we again observed an intermediate random
motility coefficient equal to 114.30 ± 11.92 µm2/min. Table 3.2 lists all random motility
coefficients for all combined chemokinesis values tested.
It is known that CCL19 and CCL21 elicit different responses upon CCR7
engagement, and the synergy we observed in our combined chemokinesis experiments is
most likely a direct result of this. The CCR7 receptor is recycled upon chemokine binding
with CCL19 eliciting rapid internalization when compared to CCL21; furthermore, once
internalized, CCL19 is targeted for degradation while CCL21 is not [60-62]. We suspect
that larger quantities of free CCL21 is capable of binding to CCR7 since it is not targeted
for degradation. This would lead to increased unbound CCR7 on the cell surface that can
then be engaged to promote increased chemokinesis through CCL21 engagement. To test
this hypothesis, we could employ using a CCR7-GFP construct to quantify internalization
upon simultaneous engagement of CCL19 and CCL21 in our experimental system.
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Furthermore, we could verify whether the CCR7 receptor co-localizes with endosomes for
recycling or lysosomes for degradation and how the concentration of each chemokine
dictates this. These data would provide further insight into how T lymphocytes respond to
combinatorial chemokine signaling and the effect on their motility in conditions possibly
similar to what is seen in SLOs.
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Figure. 3.16. sCCL19 and sCCL21 synergize for combinatorial chemokinesis on low
ICAM-1 surfaces. Combined chemokinesis of sCCL19 and sCCL21 show that motility is
increased to levels greater than what is observed with each chemokine individually. Peak
in chemokinesis observed at 1 nM sCCL19 and sCCL21 (µ = 203.00 ± 11.45 µm 2/min).
Each average value is calculated from at least three independent experiments.
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Table 3.2. Random motility coefficient values for combined chemokinesis with sCCL19
and sCCL21 on low ICAM-1 surfaces. Values of the random motility coefficients for all
chemokine variations tested. SEM = standard error of the mean.
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Figure. 3.17. Single cell traces for combinatorial chemokinesis. Single cell migration
tracks showing random motility on (A) 0.05 µg/ml of ICAM-1 alone (B) 1nM soluble
CCL19 and 1 nM soluble CCL21 (C) 20 nM of printed CCL21 and (D) 20 nM of printed
CCL21 with 100 nM soluble CCL19 with no preferred direction in migration.
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Printed CCL21 and soluble CCL19 promote robust chemokinesis on ICAM-1
surfaces
We have demonstrated that soluble CCL19 and CCL21 can lead to combinatorial
chemokine signaling with enhanced levels of motility. It is well understood that CCL21 is
capable of triggering integrin-dependent adhesion of peripheral blood T lymphocytes under
shear flow in vitro, and is displayed to flowing lymphocytes at the surface of high
endothelial venules (HEVs) and within the T cell zones of the SLOs [63, 64]. CCL19, on
the other hand, is not presented on a surface in large enough quantities but rather expressed
in soluble form to act upon their common receptor, CCR7 [6, 65]. Furthermore, it is not
well understood why two chemokine ligands capable of binding the same receptor are
expressed in the same regions, but it can be thought that one, CCL21, promotes T
lymphocyte binding to the HEVs while soluble CCL19, in concert with CCL21, is needed
for recruitment of T lymphocytes to the T cell zones of the SLOs. To further understand
the contribution of ligand presentation to T lymphocyte motility, we performed
chemokinesis experiments that mimic the expression pattern of these chemokines in vitro
by exposing primary human T lymphocytes to microcontact printed CCL21 (hCCL21)
along with varying concentrations of soluble CCL19 (sCCL19) on low ICAM-1 surfaces.
We observed with the addition of varying sCCL19 concentrations to ICAM-1 with
hCCL21 there were no significant differences in speed with values ranging between 8.57
± 0.55 to 10.27 ± 0.41 µm/min (Figure 3.18A; left panel). For persistence times, there was
no significant differences with varying sCCL19 concentrations but a peak was observed at
100 nM with a P of 7.02 ± 2.43 minutes (Figure 3.18A; middle panel). This value is
essentially half of what was observed at 100 nM sCCL19 on low ICAM-1 without hCCL21.
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The previous observed inverse correlation between speed and persistence time was lost
with the addition of sCCL19 to hCCL21; the speed remains constant while persistence
times shift (Figure 3.18A; right panel). However, these speeds do correlate to our previous
observations at 20 nM of sCCL19 and sCCL21 alone.
The addition of hCCL21 to low ICAM-1 surfaces in the absence of sCCL19 more
than doubles the random motility coefficient of cells compared to values observed on low
ICAM-1 alone (195.55 ± 14.1 versus 83.37 ± 26.7 µm2/min; Fig. 3.17A, Fig. 3.17C). When
sCCL19 concentrations were varied, a peak in motility was observed at 100 nM of sCCL19
with a random motility coefficient value of 275.63 ± 31.3 µm2/min (Figure 3.18B; p <
0.05). This is the largest random motility coefficient recorded in all sets of experiments
indicating the importance of the difference in presentation patterns for CCL19 and CCL21.
Due to CCL19 and CCL21 both being constitutively expressed by stromal cells within the
T cell zones and CCL21 expressed by the HEVs, these data may represent what is seen
physiologically and further indicates possible requirements for T lymphocyte recruitment.
By printing CCL21, we have shown that T lymphocytes are capable of robust
migration on ICAM-1 with high speeds, and with the addition of 100 nM sCCL19, T
lymphocytes have an increased persistence time which may assist in increased directional
migration required for recruitment to the SLOs.
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Figure. 3.18. hCCL21 and sCCL19 induce chemokinesis on low ICAM-1 surfaces. (A) T
lymphocyte speeds and persistence times on hCCL21 and varying sCCL19 concentrations
(left two panels); speed remains constant with a peak in persistence time at 100 nM
sCCL19. The right graph indicates a loss of the inverse correlation between speed and
persistence time. (B) Peak in hCCL21 and sCL19 chemokinesis at 100 nM sCCL19 with
the highest observed µ = 275.63 ± 31.3 µm2/min; *p < 0.05, compared to no CCL21; onesample t test The error bars represent the standard error of the mean ± (s.e.m.).
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CONCLUSIONS
In this chapter, we measured the migration of primary human T lymphocytes on
ICAM-1 and VCAM-1 microcontact printed PDMS surfaces. Our results show that ligand
composition and concentration are essential in controlling spontaneous and robust T
lymphocyte motility by modulating their speed, persistence time, and thus their random
motility. These haptokinesis studies also demonstrated that through non-Brownian motion
T lymphocytes are more active on ICAM-1 than VCAM-1 surfaces. From chemokinesis
studies on low ICAM-1 surfaces, we have demonstrated that chemokine signaling elicits
biphasic motility with peaks in the random motility coefficient near 20 nM for both of the
CCR7 ligands CCL19 and CCL21 and is dependent on ligand concentration.

By

combining both soluble CCL19 and CCL21, T lymphocyte motility was increased to levels
above what was observed by each chemokine individually through synergistic effects. We
also demonstrated that by microcontact printing CCL21, we can double the motility of T
lymphocytes on ICAM-1, and with the addition of soluble CCL19, we can further increase
motility to levels that are higher than exposure to both soluble CCL19 and CCL21,
combined or individually. These data provides insight into the dynamic behavior of T
lymphocytes and the roles of ligand, chemokines, and combinatorial signaling in an effort
for controlling motility to and within the SLOs. Furthermore, our finding that the motility
of T lymphocytes is not diffusive is consistent with measurements of made of the migration
of murine CD8+ T lymphocytes in vivo which undergo Levy walks in response to
CXCL10; this is believed to enhance the ability of T lymphocytes to encounter rare targets
with more efficiency than Brownian motion walkers [33].
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Our work in this chapter follows upon work from the Irvine laboratory on the
motility of murine T lymphocytes on surfaces coated with ICAM-1, VCAM-1, and
fibronectin. In contrast to what we showed here on microcontact printed surfaces, they did
not observe significant random motility on any adhesive ligand by itself [5]. We attribute
this difference to the exquisite control over non-specific interactions that can be achieved
on microcontact printed surfaces. However, consistent with what was shown here, the
chemokine CCL21 enhanced motion, and that enhancement was dependent on the presence
of an adhesive ligand. They did not investigate the effects of printing hCCL21 on surfaces,
quantify the random motility coefficient under any conditions, or identify the synergy of
motility from two different chemokine molecules [5]. As we previously showed with
neutrophils, our ability to print molecules on substrates allows us to identify modes of
motility that cannot be observed on traditional surfaces [26].
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CHAPTER 4: LFA-1 and VLA-4 MEDIATED MIGRATION UNDER SHEAR
FLOW
Adapted from: Dominguez GA, Anderson NR, and DA Hammer. “The direction of
migration of T-lymphocytes under flow depends upon which adhesion receptors are
engaged.” Intergrative Biology. Under revision.
NR Anderson contributed to the integrin profiling via flow cytometry.
ABSTRACT
T-lymphocyte migration is important for homing, cell trafficking, and immune
surveillance. T-lymphocytes express lymphocyte function-associated antigen-1 (LFA-1;
αLβ2) and very late antigen-4 (VLA-4; α4β1), which bind to their cognate ligands,
intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1).

These adhesive interactions provide T-lymphocytes with the ability to

withstand hemodynamic shear forces to facilitate adhesion and migration along the blood
endothelium. Recently, work has been shown that T-lymphocytes will crawl upstream
against the direction of flow on surfaces functionalized with ICAM-1. Here, we have
investigated whether the identity of the receptor and the magnitude of its engagement
affects the direction of T-lymphocyte migration under flow. We used microcontact printed
ICAM-1 and VCAM-1 PDMS surfaces on which density and type of adhesion molecule
can be tightly controlled and non-specific adhesion adequately blocked. Using a laminar
flow chamber, we demonstrate that T-lymphocytes migrate either upstream or downstream
dependent upon ligand type, ligand concentration and shear rate. We found that Tlymphocytes migrate upstream on ICAM-1 but downstream on VCAM-1 surfaces – a
behavior unique to T-lymphocytes. By varying concentrations of ICAM-1 and VCAM-1,
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we observe directed migration under flow that is dependent upon the type and
concentration of ligand. At high shear rates (800 s-1), T-lymphocytes favor upstream
migration when any ICAM-1 is present, even in the presence of substantial VCAM-1.
These results indicate that T-lymphocytes exhibit two different modes of motility –
upstream or downstream – depending on ligand composition and the shear rate.
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INTRODUCTION
For efficient homing, T-lymphocytes must withstand the hemodynamic forces
caused by fluid flow to effectively adhere and migrate along the endothelium [1, 2]. Tlymphocytes express the integrins lymphocyte function-associated antigen-1 (LFA-1;
αLβ2) and very late antigen-4 (VLA-4; α4β1), which bind to the ligands intercellular
adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1),
respectively. These integrins are known to be crucial for cell activation and to facilitate
interactions with other leukocytes in order to elicit effector functions [3-5]. LFA-1 and
VLA-4 are also required for firm adhesion to the blood endothelium under shear flow to
permit migration into lymph nodes or inflamed tissues [6-8].
Previous work has shown the rather fascinating phenomenon that murine Tlymphocytes crawl efficiently against the direction of flow on immobilized ICAM-1 and
ICAM-2 surfaces while undergoing recurrent downstream arrest on VCAM-1 [9]. Valignat
et al. demonstrated that both freshly isolated and effector human T-lymphocytes increase
their upstream migration against flow as shear rate increases on ICAM-1 surfaces [10].
Furthermore, T-lymphocytes undergo adhesion strengthening on ICAM-1 surfaces upon
spontaneous LFA-1-mediated adhesion under shear flow that is dependent upon
calcium/calmodulin signaling and the assembly of the actin cytoskeleton [11].
Often, multiple integrins are engaged, and a question that has not been fully
addressed is how the engagement of multiple integrins controls T-lymphocyte motility
under shear flow [12-15]. It is known that chemokine engagement leads to increased
integrin activation through heterologous modulation (inside-out signaling) [16-18]; on the
other hand, homologous modulation, when one integrin binds its specific ligand activating
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a signaling pathway that then activates a different integrin, can also occur. For example,
VCAM-1 engagement of VLA-4 is known to regulate β2-dependent adhesion under flow
on ICAM-1 surfaces [5, 19, 20]. Previous studies have also shown a synergistic response
in adhesion strengthening and resistance to shear upon plating human T-lymphocytes on
surfaces that have been co-immbolized with ICAM-1 and VCAM-1 [19]. However, it is
not well understood how the simultaneous engagement of LFA-1 and VLA-4 with their
cognate ligands controls the directional migration of T-lymphocytes under fluid flow,
which is especially interesting given the dichotomous response of T-lymphocytes on each
ligand alone.
In Chapter 3, we demonstrated that human primary T-lymphocytes are capable of
spontaneous and robust migration under static conditions on microcontact printed ICAM1 and VCAM-1 PDMS surfaces, but it is not well understood how the application of shear
modulates this behavior. Here, we used the same surfaces, presenting ICAM-1 and
VCAM-1 in a controllable ratio, to measure how ligand presentation affects directional
migration under fluid flow. We quantified T-lymphocyte migration under shear flow using
a parallel plate laminar flow assay [10, 11, 21-23]. We show that under conditions of shear
flow, T-lymphocytes can crawl either upstream or downstream, and the motility is
dependent upon ligand concentration, type, and shear rate, over a range of physiological
shear rates mimicking conditions encountered in the postcapillary venules where leukocyte
extravasation predominantly takes place [24, 25]. Furthermore, we show that presentation
of both ICAM-1 and VCAM-1 at different densities orients T-lymphocyte migration either
upstream or downstream of fluid flow at low shear rates while at high shear rates
preferential migration is observed upstream provided there is any ICAM-1 present. These
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results suggest that β2 integrins play a dominant role in dictating the direction of migration
under fluid flow. Our current observations correspond well to the previous studies showing
that VCAM-1 mediated motility exhibits lower migration speeds and, overall, less motility
than on ICAM-1 surfaces and provides new insight into their behavior on surfaces
containing both ligands under shear flow [26].
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MATERIALS AND METHODs
Cell Culture and Reagents
Human blood was obtained via venipuncture from healthy adult donors and
collected into sterile tubes containing sodium heparin (BD Biosciences, San Jose, CA).
These experiments involved human T-lymphocytes which were obtained by fractionation
of whole blood. Whole blood was obtained by phlebotomy, in compliance with relevant
laws and institutional guidelines for the University of Pennsylvania. The institutional
review board (IRB) of the University of Pennsylvania reviewed and approved the
protocols. Donations were made voluntarily and in all cases, informed consent was
obtained. Blood samples were carefully layered in a 1:1 ratio of whole blood to 1-Step
Polymorphprep (Axis-Shield, Oslo, Norway). Vials were then centrifuged at 1500 rpm for
35 minutes and the mononuclear band was collected into a fresh vial. Cells were cultured
in RPMI-1640 supplemented with 10% FBS and 1 μg/ml of phytohemagglutinin (PHA-M;
Sigma-Aldrich, St. Louis, MO) overnight. After 24 hours, the lymphocyte suspension in
the PHA medium was transferred into a new flask leaving behind adherent cells. After an
additional 48 hours, the cells were then cultured in RPMI-1640 with 10% FBS and 1%
penicillin-streptomycin supplemented with 20 ng/ml of interleukin-2 (IL-2; Roche,
Mannheim, Germany). Cells were used for experimentation following an additional 72
hours in culture. Other biological reagents included: protein A/G (Thermo Scientific,
Rockford, IL), human ICAM-1/Fc and VCAM-1/Fc (R&D Systems, Minneapolis, MN),
human IgG1 (Abcam, Kendall Square, MA), human anti-β2 (clone IB4) (Calbiochem, San
Diego, CA), human anti-β1 (clone Mab13) and rat isotype IgG2a (BD Pharmingen, San
Jose, CA), and Pluronics F127 (Sigma-Aldrich, St. Louis, MO). Fluorescent conjugates of
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anti-αL (clone HI111), anti-αM (clone ICRF44), anti- α4 (clone 9F10), anti- β1 (clone
TS2/16), and anti- β2 (clone 6.7) as well as the isotype controls were obtained from
eBioscience (San Diego, CA).
Substrate preparation
Poly(dimethylsiloxane) (PDMS) (Sylgard 184 Silicone Elastomer, Dow Corning,
Midland, MI) coated slides were prepared from 1 mm thick precleaned microscope slides
(Fisher Scientific, Hampton, NH) with 25 X 75 mm dimensions spin coated with degassed
PDMS (10:1 base:cure by weight) and cured overnight at 65 ºC.
Protein printing and blocking
Flat stamps for printing were prepared by pouring degassed PDMS mixed at 10:1
base:cure by weight over an unpatterned silicon wafer. The polymer was cured for 2 hours
or longer at 65 ºC. Stamps were trimmed, sonicated in 200 proof ethanol for 10 minutes,
rinsed with dH2O, and dried in a stream of N2(g). For motility studies, stamps were 1 cm2
and were inked with 200 µl of 2 µg/ml of protein A/G in PBS for 2 hours at room
temperature. The stamps were then thoroughly rinsed in H2O and blown dry with a stream
of N2. In parallel, the PDMS spincoated microscope slide was treated with ultraviolet
ozone for 7 minutes (UVO Cleaner Model 342, Jelight Company, Irvine, CA) to render the
surface hydrophilic. The stamp was then placed in conformal contact with the substrate
for ~10 seconds and removed. A 0.2% (w/v) solution of Pluronics F127 was immediately
adsorbed to the PDMS substrates for 30 minutes at room temperature to prevent protein
adsorption to non-functionalized portions of the PDMS. The cell culture substrate was
then rinsed with PBS 3X without dewetting the functionalized surface before deposition of
200 µl of either ICAM-1/Fc, VCAM-1/Fc, or ICAM-1/Fc and VCAM-1/Fc in PBS for 2
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hours at room temperature. Ligand concentrations of the substrates were controlled by
varying ratios of ICAM-1/Fc and VCAM-1/Fc to human IgG1. For all experiments (unless
otherwise noted), effective total protein concentration remained constant at 10.0 µg/ml.
Lack of unspecific T-lymphocyte interactions with the PDMS substrates was tested in
control experiments using protein A/G surfaces blocked with 0.2% Pluronics or protein
A/G overlaid with a saturating concentration of human IgG1.
Flow Cytometry
Cells were prepared at 5 X 106 cells/ml in 1 ml total volume of flow cytometry
buffer (5% FBS in PBS). 100 μl of cells were incubated with 5 μl of either FITC anti-αL
(clone HI111), FITC anti-αM (clone ICRF44), PE anti- α4 (clone 9F10), FITC anti- β1
(clone TS2/16), and FITC anti- β2 (clone 6.7) as well as the isotype controls for 30 minutes
at 4ºC. Cells were then washed 3X with flow cytometry buffer via centrifugation at 1500
rpm for 5 minutes each. Cells were then resuspended into a final volume of 750 μl of flow
cytometry buffer. Cells were analyzed using a BD FACSCalibur (Franklin Lakes, NJ)
instrument followed by data processing using FlowJo (Ashland, OR).
Flow Chamber Assembly and Assay
A parallel-plate flow chamber (GlycoTech, Gaithersburg, MD) was used with the
prepared PDMS substrate. The channel template was cut from 0.01-inch-thick Duralastic
sheeting (Allied Biomedical, Goose Creek, SC). For each flow experiment, the template
was placed over the prepared PDMS coated slide. The template and slide were placed in
the bottom well of the flow chamber, and the top was secured with screws. The chamber
was assembled under water to minimize the introduction of air. It was then mounted on
the microscope in a 5% CO2 and 37°C environment for 10 minutes to allow for
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equilibration.

Before introduction of T-lymphocytes, the chamber was flushed with

running media consisting of RPMI-1640 supplemented with 0.1% BSA and 2 mg/ml
glucose. A volume of 1.5 ml containing 1 X 106 cells in running media was introduced
into the chamber and cells were allowed to attach for 15 minutes. Fluid flow was initiated
using a syringe pump (11 Plus, Harvard Apparatus, Holliston, MA) and volumetric flow
rates were adjusted accordingly to correspond to desired shear rates. Shear rate was
calculated using 𝜏𝑤 =

6𝜇𝑄
2

ℎ 𝑤

where µ is the fluid viscosity, Q is the volumetric flow rate, h

is the channel height and w is the channel width. For this chamber, h = 0.023 cm, w = 0.1
cm. Images were captured every minute on a motorized stage and observed using a Nikon
Eclipse TE300 phase contrast microscope. Images were captured using a 10X objective.
Migrating cells had a polarized morphology consisting of a lamellipod at the front and a
uropod at the rear; spherical and non-adherent cells were either washed away upon
application of flow or demonstrated no motility and were not included in analysis.
Antibody Blocking
Functional blocking antibodies against the β1 integrin subunit (clone Mab13), β2
integrin subunit (clone IB4), and IgG2a isotype control (clone R35-95) were used at a final
concentration of 50 µg/ml. 1.5 X 106 T-lymphocytes in 500 µl of running media were
incubated for 30 minutes with antibodies at 37C and 5% CO2. Cells were then injected
into flow chamber apparatus and allowed to adhere in the absence of flow for 15 minutes.
Running buffer consisted of RPMI-1640 supplemented with 0.01% BSA, 2 mg/ml glucose,
and 1/10 final antibody blocking concentration. Cells were exposed to flow for 30 minutes
before quantification of speed and MI.
Measurement of Cell Trajectories, Speed, and Migration Index
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Cell movement was tracked using the ImageJ plugin Manual Tracking. ImageJ and
the plugin are both freely available through the NIH website (http://rsbweb.nih.gov/ij/).
The centroid of the cell was considered to represent the cell position. Time lapse
microscopy was used and images were taken every minute. The result was a series of (xi,yi)
positions with time for each cell. The net displacement during the 𝑖th 1.0 minute
increment, 𝐷𝑖 , was calculated by the difference of the position at the beginning and end of
that time step. The sum of total displacements (Di,accum) was used to calculate the cell speed
over the entire experimental time course of 30 minutes. The migration index (MI) was
defined as the ratio of the difference between the initial and final x-displacement to total
displacement where 𝑀𝐼 =

𝑥𝑖,𝑒𝑛𝑑 −𝑥𝑖,𝑖𝑛𝑖𝑡𝑖𝑎𝑙
𝐷𝑖,𝑎𝑐𝑐𝑢𝑚

. Values of the migration index near +1, indicate

that cells migrate in a straight trajectory against the direction of flow while values near -1,
indicate a preference of migration in a straight trajectory along the direction of flow. When
the MI is near 0, there is no preferred direction in migration indicating random motility.
Surface quantification
Protein A/G stamped surfaces were prepared as described above. Fluorescently
labeled human IgG1 was prepared using 1 mg of human IgG1 and the Alexa Fluor® 555
Protein Labeling Kit (Life Technologies, Grand Island, NY). Concentration and degree of
labeling of the sample was calculated as described in the provided procedure. Solutions of
fluorescently labeled and unlabeled human IgG1 were mixed together in varying
combinations and deposited onto stamped protein A/G surfaces for 2 hours. Surfaces were
then rinsed with PBS 3X without dewetting the functionalized surface before mounting on
the microscope. A 20X objective was used to image.. Pixel intensities were calculated
using ImageJ by averaging over four distinct areas in the field of view across a minimum
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of four different locations on each surface. A solution of unlabeled human IgG1 was used
as a control.
Immunofluorescence
Parallel flow chamber assays were performed as described above.

Upon

completion of experiments, the cells were fixed with 4% paraformaldehyde in PBS for 7
minutes that was flowed through at the experimental shear rate. The substrate was removed
from the flow chamber apparatus and then permeabilized with 0.2% Triton X-100 for 5
minutes and blocked with 1% BSA in PBS for 30 minutes at room temperature. Cells were
incubated with 1:200 Alexa Fluor 568-labeled phalloidin and Alexa Fluor 488-labeled
mouse anti-α tubulin (Invitrogen) for 30 minutes at room temperature. Cells were mounted
in Fluoromount-G mounting medium (SouthernBiotech, Birmingham, Alabama) and
examined by confocal microscopy (Leica SP5).
Data analysis
Data are presented as mean ± SEM. Statistical significance was computed using
one-way ANOVA and pairwise comparisons were performed with the student t test.
Values of p are indicated in the figures or figure legends.
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RESULTS AND DISCUSSION
Microcontact printing of Protein A/G and Surface Quantification
We verified the relative composition of our surfaces using fluorescently tagged
human IgG1 molecules that bind to microcontact printed protein A/G. Briefly, Alexa Fluor555 tagged IgG1 (IgG1-555) was mixed with unlabeled human IgG1 in different ratios to
maintain a total protein solution concentration of 20 μg/ml. Figure 1A-F shows the
fluorescence intensities of surfaces with increasing concentrations of IgG1-555.

By

quantifying the pixel intensities for each condition, we found a linear correlation (R2 =
0.991) between IgG1-555 concentration and pixel intensity (Fig. 4.1G). These data allows
us to conclude that as we increase ligand concentration within solution, we are
proportionately increasing the amount of ligand on our surfaces, up to a solution
concentration of 20 μg/ml IgG1. This range of concentrations cover what was used to
prepare our surfaces.
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Figure 4.1. Increasing solution concentrations of Fc-containing ligand correlates to
increasing surface ligand concentrations. Fluorescent images of surfaces prepared with
increasing concentrations of Alexa Fluor-555 tagged human IgG1 (IgG1-555). Solution
concentrations of IgG1-555 depicted are as follows: A) 0 μg/ml, B) 1 μg/ml, C) 5 μg/ml,
D) 7.5 μg/ml, E) 10 μg/ml, and F) 15 μg/ml. G) The pixel intensities were calculated for
each concentration and plotted. Data reveals a linear correlation between soluble IgG1555 concentration and fluorescent signal present on the surface (R2 = 0.991). Data are
mean ± SE. Scale bar = 50 μm.
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ICAM-1, but not VCAM-1, supports T-lymphocyte migration against the direction of
flow as a function of shear rate
Intraluminal crawling under shear flow is required for T-lymphocyte extravasation
and is dependent upon engagement of integrins to support adhesion and migration [27].
Recently, Valignat et al. showed that primary human T-lymphocytes crawl against fluid
flow in a shear dependent manner on ICAM-1 surfaces [10]. In this study, we extend upon
this recent work and report upon the effect of substrate chemistry on the directionality of
primary human T-lymphocyte migration under fluid flow. T-lymphocytes express the
integrin heterodimers VLA-4 and LFA-1, and we employed flow cytometry to confirm the
expression of αL, α4, β1, and β2 on primary human T-lymphocytes (Fig. 4.2). We also
verified that our cells do not express the MAC-1 integrin heterodimer (αMβ2) which is
capable of binding to ICAM-1, allowing us to conclude that the interactions observed on
ICAM-1 are solely due to LFA-1 engagement.
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Figure 4.2. Expression of LFA-1, VLA-4, and MAC-1 on primary human T-lymphocytes.
(A) The expression levels of the three integrin α subunits αL (red), αM (blue), and α4 (green).
(B) The expression levels of the two integrin beta subunits β2 (red) and β1 (blue). All
negative controls are depicted in gray. Plots represent one set of data from three separate
experiments.
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Through the use of a parallel flow chamber, we quantified cell motility under fluid
flow on substrates with different adhesive ligands in the absence of chemokine. The
motility of cells at different shear rates was measured on surfaces prepared by incubating
either 5 µg/ml of ICAM-1 or VCAM-1 onto surfaces stamped with protein A/G. After
injection and a resting time of 15 minutes to allow for adhesion, cells were exposed to shear
rates of 100, 200, 400, or 800 s-1. As illustrated by representative cell traces (Fig. 4.3. A
and F), T-lymphocytes migrated substantial distances under static conditions on ICAM-1
or VCAM-1 surfaces, and upon application of flow, directional responses were observed.
Blue traces indicate cells that traveled upstream in fluid flow while red traces indicate cells
that traveled downstream. At a low shear rate of 100 s-1, cells on ICAM-1 surfaces showed
a slight preference for migrating upstream, and with increasing shear rates, cells on ICAM1 surfaces showed an increasing preference to migrate upstream (Fig. 3, B-E). In contrast,
cells on VCAM-1 surfaces preferred to migrate downstream with little to no migration
upstream at any shear rate (Fig. 4.3, G-J). To quantify the directional motion, we calculated
the migration index (MI) for all cells, defined as the ratio of total x-displacement to total
overall displacement, with positive values indicating motion upstream and negative values
indicating motion downstream. Under static conditions, the MIs for cells on ICAM-1 and
VCAM-1 were near 0, indicating random migration with no preference in direction. Upon
exposure to flow, cells on ICAM-1 migrated upstream with increasing MIs as a function
of increasing shear rate with values ranging from 0.21 to 0.38 (Fig. 4.3K). On VCAM-1
substrates, migration was downstream with MIs having no dependence on shear rate with
values between -0.69 and -0.77 (Fig. 4.3K). Furthermore, T-lymphocytes exposed to
surfaces of protein A/G alone did not adhere allowing us to assume that the observed
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directional migration on ICAM-1 and VCAM-1 surfaces is specifically due to the ligation
of adhesion receptors, and not due to non-specific interactions.
As shear rates increased, we observed a decrease in migration speed on both ligands
(Fig. 3L). We observe higher migration speeds on ICAM-1 than VCAM-1 under flow,
which corresponds to previous observations under static conditions [26]. On ICAM-1
surfaces, a significant decrease in speed was seen at larger shear rates (400 s-1 and 800 s-1)
compared to under static conditions. The peak speed was observed at 100 s-1 (11.47 ± 0.93
µm/min) with the lowest speed observed at 800 s-1 (7.97 ± 0.30 µm/min). For VCAM-1
surfaces, application of 100 s-1 of fluid flow doubled the migration speed (5.93 ± 0.52
µm/min) compared to what was observed under static conditions (3.44 ± 0.33 µm/min).
Furthermore, when shear rates were increased further on VCAM-1 substrates, the
migration speeds decreased with increasing shear rate with the lowest speed being observed
at 800 s-1 (4.08 ± 0.33 µm/min).
The integrins LFA-1 and VLA-4 are known to be mechanoresponsive to force,
leading to increased activation and adhesion stabilization [2, 11, 21, 23, 28]. We expect
that as shear rate is increased the integrin-ligand bonds strengthen to promote adhesion and
migration. Overall, increasing shear rates led to an increase in the orientation of migration
upstream of fluid flow on ICAM-1 surfaces but not VCAM-1 surfaces. These unique
responses are likely caused by the inherent differences between these two integrins and
their roles physiologically. The integrin LFA-1 binds to ICAM-1 and is required for firm
adhesion and extravasation under fluid flow after transient adhesion events and chemokine
exposure. Therefore, it appears that LFA-1/ICAM-1 interactions secure adhesion and
promote lamellipodial extension upstream. VLA-4, on the other hand, is capable of
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supporting both tethering and rolling (in the absence of other adhesion ligands) through
engagements with VCAM-1 and is required for capture of T-lymphocytes from fluid flow.
Furthermore, after chemokine exposure, VLA-4 increases its affinity to promote firm
adhesion and, along with LFA-1, mediates migration along the blood endothelium
supporting diapedesis through the endothelium [4, 27, 29, 30].

Although VLA-4

participates in transient as well as firm adhesion events, we hypothesize that this integrin
facilitates weaker adhesions compared to LFA-1 and cannot stabilize upstream
interactions. Under flow, VLA-4 most likely supports a passive form of adhesion that can
support downstream migration and prevent T-lymphocytes from being swept away but not
facilitate migration upstream.

This has been proposed in other cell types, such as

neutrophils, and is hypothesized to be due to lack of a mechanosensing mechanism through
this receptor [10, 31].
An alternate hypothesis for T-lymphocytes migrating either upstream or
downstream of flow may lie in the integrin expression patterns and their specific
interactions with cytoskeletal proteins. Integrin molecules and cytoskeletal linker proteins
support bidirectional transmission of force by linking the extracellular matrix (ECM) and
the actin cytoskeleton [32, 33]. Application of force is known to strengthen this linkage
preventing slippage between the actin cytoskeleton and integrin molecules allowing them
to sustain much larger forces [34-36]. Talin, a cytoskeletal linker protein, is known to
associate with high affinity conformation states of LFA-1 and VLA-4 on migrating Tlymphocytes [37-39]. These higher affinity forms of VLA-4 are expressed at the leading
edge while the higher affinity forms of LFA-1 are expressed in the mid-cell to rear regions
of migrating T-lymphocytes [14, 38]. Recent traction force microscopy (TFM) studies
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have shown that actomyosin contraction occurs in the rear region of neutrophils thus
generating the traction stresses required for cell translocation and motility [31, 40]. The
activated LFA-1 found in the mid-cell to rear regions of a migrating T-lymphocyte might
support the traction necessary for the actomyosin contractility in the rear to generate the
upstream migration against shear. VLA-4, on the hand, may not generate enough traction
- given its localization at the front of cell - to support upstream motion but rather permits
the more passive form that is dictated by the fluid flow. We would expect to observe large
traction stresses generated on ICAM-1 in the rear while more forces would be found in the
front on VCAM-1. Furthermore, unlike previous studies, we observed decreased speeds
with increasing shear rate on both ICAM-1 and VCAM-1 surfaces [10]. A possible
explanation for the increased speed of upstream migration is the increase in the modulation
of integrin-ligand affinity that leads to greater adhesive interactions [41, 42].
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Figure 4.3. T-lymphocytes crawl against the direction of flow on immobilized ICAM-1
but not on VCAM-1 to an extent that depends on shear rate. A-E) Cell traces of Tlymphocytes under shear flow (right to left) on ICAM-1 (5.0 µg/ml) and F-J) VCAM-1
(5.0 µg/ml) coated PDMS surfaces under varying shear rates. The traces depicted under
flow are for one representative experiment in each group. Blue traces indicate cells that
traveled upstream of flow while red traces indicate cells that traveled downstream. Black
arrow indicates direction of shear flow for all conditions. Traces are in µm. K) The
direction of T-lymphocytes under shear flow as expressed as the migration index (MI). A
positive MI indicates migration against the flow (upstream) while a negative MI indicates
migration in the direction of flow (downstream). T-lymphocytes on ICAM-1 migrate
upstream to an increasing extent with increasing shear rate while cells on VCAM-1 migrate
downstream. The MI was calculated from T-lymphocyte tracks from three independent
experiments. *p < 0.05. L) T-lymphocytes on ICAM-1 migrate faster than cells on
VCAM-1 and is decreased at higher shear rates. Migration speeds were calculated from
three independent experiments each. *p < 0.05.
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Downstream migration of T-lymphocytes is dependent upon VCAM-1 concentration
We have previously demonstrated that the concentration of ICAM-1 and VCAM-1
controls cell speed and the random motility of primary human T-lymphocytes [26]. We
investigated whether this is also true under shear flow. We exposed cells to shear rates of
100 s-1 and 800 s-1 on ICAM-1 surfaces coated with 0.5, 1.0, 5.0, and 10.0 µg/ml of ICAM1 Fc chimera. Representative cell traces shows that T-lymphocytes preferred to migrate
upstream on ICAM-1 for both shear rates (Fig. 4.4, A-D, E-H). We calculated the
migration index for each condition to ascertain whether ligand concentration affects the
directionality of migration along with shear rate. At a shear rate of 100 s-1, the MIs ranged
between 0.14 to 0.21, and upon application of 800 s-1, these values increased significantly
and ranged from 0.33 to 0.46 (Fig. 4.4I) with no dependence on ligand concentration for
both shear conditions. For the lower concentrations of 0.5 and 1.0 µg/ml of ICAM-1, there
were no differences in the speed of T-lymphocytes between shear rates of 100 s-1 and 800
s-1 (Fig. 4.4J). On surfaces prepared with concentrations of 5.0 and 10.0 µg/ml of ligand,
speeds significantly decreased when shear rate increased from 100 s-1 to 800 s-1.
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Figure 4.4. T-lymphocytes crawl upstream on different concentrations of immobilized
ICAM-1. A-D). Cell traces of T-lymphocytes crawling at a shear rate of 100 s-1 on varying
concentrations of ICAM-1 PDMS surfaces. E-H) Cell traces of T-lymphocytes under 800
s-1 of shear flow on varying concentrations of ICAM-1 PDMS surfaces. Black arrow
indicates direction of shear flow for all conditions. The traces depicted under flow are for
one representative experiment under the stated conditions. I) The direction of Tlymphocyte migration under shear flow expressed as the migration index (MI). Tlymphocytes on ICAM-1 surfaces migrate upstream and directionality depends on shear
rate. The MI was calculated from T-lymphocyte tracks from three independent
experiments. *p < 0.05. J) T-lymphocytes on varying concentrations of ICAM-1 migrate
with the same speed at each shear rate tested . Migrations speeds were calculated from
three independent experiments each. *p < 0.05
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We also measured the motility of T-lymphocytes on VCAM-1 surfaces prepared at
0.5, 1.0, 5.0, and 10.0 µg/ml of the VCAM-1 Fc chimera. The representative cell traces
show that at shear rates of 100 s-1 (Fig. 5, A-D) and 800 s-1 (Fig. 5, E-H) cells crawl
downstream for all VCAM-1 concentrations. Unlike ICAM-1 surfaces, the MIs for cells
on VCAM-1 surfaces strongly depend upon ligand concentration. Under 100 s-1 of flow,
the MIs became more negative as VCAM-1 concentration increased, ranging from -0.33
(at 0.5 µg/ml) to -0.83 (at 10 µg/ml) (Fig. 5I). At a shear rate of 800 s-1, the effect of
ligand density is more moderate with the two lower concentrations having similar MIs (.75 and -.77) and the two larger concentrations having significantly larger values (-.88 and
-.91). On VCAM-1 surfaces exposed to a shear rate of 100 s-1, crawling speeds ranged
between 5.93 to 6.43 µm/min and were largely independent of ligand concentrations.
However, at a shear rate of 800 s-1, cells exhibited lower migration speeds at lower ligand
concentrations that doubled on surfaces made with higher ligand concentrations (3.12
versus 6.26 µm/min; Fig. 5J). Overall, upon varying ligand concentration, we observed
increased upstream migration on ICAM-1 surfaces that is dependent upon shear rate not
ligand density. On the other hand, cells migrating on increasing VCAM-1 concentrations
showed increased downstream migration as ligand density increased but only during
exposure to 100 s-1 of fluid flow.
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Figure 4.5. The migration index of T-lymphocytes crawling in the direction of flow
increases with concentration of immobilized VCAM-1. A-D) Cell traces of Tlymphocytes at a shear rate of 100 s-1 on different concentrations of ICAM-1 on PDMS
surfaces. E-H) Cell traces of T-lymphocytes at a shear rate of 800 s-1 on varying
concentrations of ICAM-1 PDMS surfaces. The traces depicted under flow are for one
representative experiment in each group. Black arrow indicates direction of shear flow for
all conditions. I) The direction of T-lymphocytes under shear flow expressed as the
migration index (MI). T-lymphocytes on VCAM-1 migrate downstream and the migration
index is dependent upon ligand concentration. The MI was calculated from T-lymphocyte
tracks from three independent experiments. *p < 0.05. J) T-lymphocytes on varying
concentrations of VCAM-1 migrate with the same speed at a shear rate of 100 s-1 but
increases speed on higher concentrations of VCAM-1 at a shear rate of 800 s-1. Migrations
speeds were calculated from three independent experiments each. *p < 0.05.
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Directional migration of T-lymphocytes under fluid flow can be controlled through
combinations of ICAM-1 and VCAM-1 under shear flow
Under homeostatic conditions, endothelial cells express basal levels of ICAM-1
and VCAM-1, and upon activation by inflammatory stimuli, expression of these molecules
is upregulated to facilitate increased cell arrest and migration [43]. It has also been shown
on murine endothelial cells that baseline expression levels of ICAM-1 are greater than
VCAM-1, and upon stimulation via known inflammatory stimuli, upregulation of these
adhesive ligands varies depending upon the tissue [44]. This motivated us to create
surfaces that present both ICAM-1 and VCAM-1 together at various densities to elucidate
how simultaneous ligation of LFA-1 and VLA-4 controls migration under fluid flow. Upon
presentation of both adhesion molecules, we expected to observe motility that was
intermediate between the behaviors of each ligand alone. Because VCAM-1 engagement
can regulate β2-dependent adhesion on ICAM-1 surfaces, crosstalk between the two
signaling pathways downstream of receptor engagement presents an additional layer of
complexity in the regulation of T-lymphocyte motility [5, 19, 20, 45]. T-lymphocytes were
plated on surfaces where the ratio of ICAM-1 and VCAM-1 was varied by changing the
ratios of ICAM-1 and VCAM-1 within solution while maintaining a constant total protein
concentration of 10 μg/ml. For example, by mixing 3 μg/ml of ICAM-1 and 7 μg/ml of
VCAM-1, equaling to a total protein concentration of 10 μg/ml, a surface called I3 + V7
was created; this surface was 30% ICAM-1 and 70% VCAM-1. On all surfaces, we
measured the direction of migration either upstream or downstream as a function of the
ratios of ICAM-1 and VCAM-1 present on the surface (Fig. 4.6). At a shear rate of 100 s1

, we observed directional responses that were dependent upon the concentrations of both
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ligands with preferred upstream migration on surfaces with higher concentrations of
ICAM-1 and preferred downstream migration on surfaces with higher concentrations of
VCAM-1. This behavior is consistent with the hypothesis that the phenotype of adhesion
is consistent with the concentration of ligand. The magnitude of the migration index for
each condition on combined surfaces is less than what is observed for each ligand
individually, again consistent with an intermediate response. Upon exposure to 800 s-1, the
presence of any ICAM-1 oriented the motion of cells upstream even when large amounts
of VCAM-1 were present. At this shear rate, only surfaces made purely of VCAM-1 (V10)
favored downstream migration.
On the other hand, upon application of 800 s-1 of fluid flow, we observe only
upstream migration if any ICAM-1 is present, independent of the concentration of VCAM1 present on the surface. It is known that adhesion strengthening occurs upon plating
human T-lymphocytes on co-immbolized ICAM-1 and VCAM-1 surfaces [19]. Together,
these observations lead us to believe that under conditions of high shear, T-lymphocytes
utilize LFA-1-ICAM-1 engagements over VLA-4-VCAM-1 engagements to resist
detachment due to shear stress. These interactions stabilize adhesions supporting upstream
migration when presented with both adhesion ligands.

This shear resistance is

hypothesized to occur as a result of outside-in integrin signaling triggered upon application
of shear stress across the body of the cell that is translated into applied tension across the
ligated integrin bonds thus increasing integrin activation.
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Figure 4.6. T-lymphocytes elicit different responses on surfaces made with both
immobilized ICAM-1 + VCAM-1 that are dependent upon shear rate. (Abbreviations: I ICAM-1; V - VCAM-1; 10 - 10 µg/ml; 7 - 7 µg/ml; 5 - 5 µg/ml; 3 - 3 µg/ml; 1 – 1 µg/ml)
The direction of T-lymphocytes under shear flow expressed as the migration index (MI)
under 100 s-1 (red bars) and 800 s-1 (blue bars). The total protein concentration was fixed
at 10 μg/ml and the ratios of ICAM-1 to VCAM-1 were varied. Directional migration is
dictated by ligand concentration at a shear rate of 100 s-1, with a substantial amount of
ICAM-1 necessary for upstream migration. However, the presence of any ICAM-1
supports upstream migration at a shear rate of 800 s-1. The MI was calculated from Tlymphocyte tracks from three independent experiments.
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T-lymphocyte resistance to shear flow is mediated through LFA-1-ICAM-1
interactions
Antibodies were used to block either the β2 or β1 integrin subunits and cells were
plated on surfaces of 5 μg/ml ICAM-1, 5 μg/ml VCAM-1, and 2.5 μg/ml ICAM-1 + 2.5
μg/ml VCAM-1. Upon blocking against the β2 integrin subunit on surfaces comprised of
ICAM-1 alone, no cell adhesion was observed under flow meaning that the MI could not
be calculated (Fig. 4.7A). The same was observed on surfaces made from VCAM-1
surfaces when the β1 integrin subunit was blocked. When T-lymphocytes were blocked
against the β2 integrin and exposed to a surface of combined ICAM-1 and VCAM-1 ligand,
we observed downstream migration of cells with fluid flow mimicking the behavior of cells
on surfaces of VCAM-1 alone. Conversely, upon blocking against the β1 integrin, the MI
was positive, indicating upstream migration - a result that was similar to what was observed
on surfaces containing ICAM-1 alone. These results show that the motility observed on
ICAM-1 and VCAM-1 surfaces under fluid flow are due to the specific interactions of the
ligand-integrin pairs.
Next, we qualitatively assessed the adhesion strength of T-lymphocytes to printed
surfaces of ICAM-1, VCAM-1, or ICAM-1 + VCAM-1, deduced by exposing cells to
increasing shear rates which were increased every 5 minutes for a period of 40 minutes.
Cells were initially injected and allowed to adhere under static conditions for 15 minutes
on surfaces of 5 µg/ml of ICAM-1, VCAM-1, or a combined surface of the two before
exposure to shear. Fluid flow was then increased incrementally from 100 s-1 to 2000 s-1
and the number of cells that remained bound from those that originally settled on the
surface was determined. Upon initial application of fluid flow at a shear rate of 100 s-1,
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approximately 20 – 30% of the cells were detached, presumably due to little or no adhesion
to any of the three ligand conditions (Fig. 4.7B). For cells on ICAM-1, increasing the shear
rate further did not decrease the number of remaining bound cells significantly (76 versus
73%). However, for cells on VCAM-1 surfaces, the number of bound cells significantly
decreased as a function increasing shear rate from 68% to 41% bound. For surfaces on
which both ICAM-1 and VCAM-1 were combined, there was no significant decrease in
number of cells bound with increasing shear rates, similar to what was found on ICAM-1
surfaces.
Flow cytometry revealed that there are larger quantities of the β2 integrin than β1
present on the cell surface; by having more LFA-1 available to bind, smaller quantities of
ICAM-1 may be capable of supporting upstream motion on the combined surfaces even in
the presence of much larger quantities of VCAM-1. Also, if there is a larger number of
activated LFA-1 versus VLA-4, this could explain why we observe more upstream motion
on combined surfaces of the two ligands especially at high shear rates. This further
supports our previous hypothesis that LFA-1 is supporting the majority of the traction
allowing the cell to resist shear flow and migrate upstream. If there are more activated
LFA-1 molecules than VLA-4 present on the surface, then greater traction can be produced.
Through a shear flow cell detachment assay we demonstrated that cells on surfaces of
ICAM-1 or combined ICAM-1 and VCAM-1 have greater resistance to shear stress than
on surfaces of VCAM-1 alone. This further supports our claim that LFA-1-ICAM-1mediated interactions are necessary for robust upstream migration and dominate under high
shear on surfaces that present both adhesive ligands. This may also explain why T
lymphocytes migrate more on ICAM-1 than VCAM-1 as seen in Chapter 3; if there is more
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β2 than β1 integrin, then possibly more motility can be supported on ICAM-1 surfaces than
compared to VCAM-1 given that there is more receptor to bind its cognate ligand.
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Figure 4.7. T-lymphocytes resist shear detachment through the β2 integrin. A) Tlymphocytes pretreated with blocking antibodies against the β1 (red bar) or β2 (green bar)
integrin subunits and were exposed to ICAM-1, VCAM-1, or ICAM-1 + VCAM-1 surfaces
under 100 s-1 of fluid flow and the MI was determined. Data are mean ±SE B) Tlymphocytes were exposed to increasing shear rates and the percent of cells remaining
bound after 5 minutes of exposure was calculated. Shear rate was increased every 5
minutes starting at 100 s-1 and ending at 2000 s-1.
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Migration on ICAM-1 or VCAM-1 is robust and reversible but not on combined
ligand surfaces
We investigated whether the directional responses of T-lymphocytes on ICAM-1,
VCAM-1, and ICAM-1 + VCAM-1 surfaces under high shear rates were reversible. We
allowed cells to migrate in periodic square waves of shear rate, alternating between no flow
and a shear rate of 800 s-1, in increments of 10 minutes for a total time of 90 minutes. This
technique is similar to that employed recently by Valignat et al [10]. At shear rates of 800
s-1, cells on ICAM-1 migrate upstream (MI ~ 0.4) while cells on VCAM-1 migrate
downstream (MI ~ -0.6) (Fig. 4.8A). Furthermore, upon application of alternating periods
of no flow and shear rates of 800 s-1, the direction of migration is reversible with a return
to a MI to nearly zero (random migration) demonstrating no memory of being exposed to
shear flow. However, for cells on the combined ligand surface (I5 + V5), this behavior was
not reversible; the MI remained positive during all periods of flow and even when the flow
was removed. The exception was the absence of flow in the initial 10 minutes (Fig. 4.8A),
when the cell had not been previously exposed to flow. During these periods of alternating
shear flow, we found no change in cell speed in the presence or absence of flow (Fig. 4.8B).
However, the average cell speeds on ICAM-1 alone during the time course of the
experiment were always greater than those observed on VCAM-1 alone. Furthermore, cell
speeds on surfaces with the combination of VCAM-1 and ICAM-1 remained between the
speeds observed for ICAM-1 and VCAM-1 independently.
T-lymphocyte upstream migration on ICAM-1 surfaces has been previously shown
to be robust and reversible with cells migrating upstream upon application of flow and
returning to random motion once it is removed [10]. We showed that motility is reversible
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on surfaces of VCAM-1 with downstream migration seen under fluid flow and random
migration upon removal.

On surfaces with ICAM-1 and VCAM-1 together, the

directionality of motility is not reversible with T-lymphocytes maintaining upstream
motion during periods of no flow. This suggests upstream motion is driven by signaling,
not physical effects such as forces from shear stresses. This implies that memory occurs
upon the removal of flow and this memory of signaling requires simultaneous ligation of
both LFA-1 and VLA-4 since it is not observed upon ligation of each integrin receptor
individually. An interesting question to ask is how long does this directional persistence
last in the absence of flow and if it is dependent upon how long the cells are exposed to
flow itself before its removal. By exposing cells to flow for longer periods of time (greater
than our tested time interval of 10 minutes), we could determine how long this persistence
of migration upstream occurs upon removal of fluid flow.
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Figure 4.8. T-lymphocytes exhibit reversible directional responses to periodic shear flow
on ICAM-1 and VCAM-1 but not on combined surfaces. A) and B) T-lymphocytes were
exposed to periodic square waves of duration of 10 min and between shear rates of 0 s -1
and 800 s-1 (shaded region) on 5 μg/ml ICAM-1, 5 μg/ml VCAM-1, and 2.5 μg/ml each of
both ICAM-1 and VCAM-1. The average MI and average speed over the 10 minute time
interval were measured.
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Shear flow leads to rearrangement of the T-lymphocyte cytoskeleton
To further investigate the mechanisms of motility of T-lymphocytes, we exposed
cells to shear flow on surfaces of 5 μg/ml of ICAM-1, VCAM-1, or combinations of the
two followed by cell fixation, permeabilization, and fluorescent labeling of the actin and
microtubule cytoskeletons. It has been previously shown that T-lymphocytes polarize on
ICAM-1 and VCAM-1 surfaces alone in the absence of chemokine with an actin-rich
lamellipod and an uropod containing the microtubule organizing center (MTOC) [26]. In
the absence of flow for all three substrates, we observe distinct cytoskeletal polarity with
actin predominantly located in the lamellipod and microtubules originating from the
(MTOC) behind the nucleus (Fig. 4.9A a-c, 4.9B a-c, 4.9C a-c). Upon the introduction of
shear flow, we observe loss of cytoskeletal polarity with increasing co-localization of actin
and tubulin on all three substrates; at both 100 s-1 and 800 s-1 shear rates, we observe this
rearrangement of cytoskeletal proteins (Fig. 4.9A d-i, 4.9B d-i, 4.9C d-i).
It has been speculated that shear stress may trigger signals or changes within the
cytoskeletal machinery in T-lymphocytes. T-lymphocyte polarity and motility is highly
dependent upon the arrangement of the actin and microtubule cytoskeletons through
signaling pathways involving the Rho family GTPases [46-48]. Upon fluorescent labeling
of the cytoskeletal proteins after exposing cells to shear flow, we observed increased colocalization of these cytoskeletal proteins, and the absence of a clearly defined lamellipod.
We hypothesize that this increased co-localization of actin and tubulin occurs in order to
withstand extracellular forces required to resist deformation caused by the shear stress.
The cellular cytoskeleton is known to be involved with several signaling pathways thus
possibly providing the signals required for adaptation to a new mechanical environment
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[49]. This has been well established in other cells types, such as endothelial cells, which
are capable of rearranging their cytoskeletons in response to fluid shear forces [50, 51].
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Figure 4.9. T-lymphocytes undergo cytoskeletal rearrangement upon application of shear
flow during migration. A) Fluorescent images of migrating T-lymphocytes on 5 μg/ml
ICAM-1 under static (a-c), 100 s-1 (d-f), and 800 s-1 (g-i) shear rates. B) Fluorescent
images of migrating T-lymphocytes on 2.5 μg/ml ICAM-1 and 2.5 μg/ml VCAM-1 under
static (a-c), 100 s-1 (d-f), and 800 s-1 (g-i) shear rates. C) Fluorescent images of migrating
T-lymphocytes on 5 μg/ml VCAM-1 under static (a-c), 100 s-1 (d-f), and 800 s-1 (g-i) shear
rates. The direction of flow is from right to left. Scale bar = 5 μm.
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CONCLUSIONS
In this chapter, we measured the motility of human T-lymphocytes on surfaces
comprised of ICAM-1, VCAM-1, or combinations of the two under varying shear rates.
Confirming previous studies, we observed upstream migration against fluid flow on
ICAM-1 surfaces. We further investigated the effects of varying ligand concentrations and
shear rates not only on ICAM-1 surfaces but also VCAM-1, as well as combinations of the
two at various densities. For cells on ICAM-1, upstream migration is not dependent upon
ligand concentration but rather shear rate, with increasing shear rates resulting in an
increase in the preferred upstream migration. Contrary to the findings by Valignat et al.,
we found that migration speed decreases with increasing shear rate likely contributed to
the increased strengthening of LFA-1-ICAM-1 interactions as a result of fluid flow [10].
Steiner et al. also showed that T-lymphocytes do not crawl on VCAM-1 surfaces but rather
undergo recurrent arrest with an absence in cell polarization. We found the opposite - cells
polarized and migrated downstream and were found to be dependent upon ligand density
and, to a lesser extent, shear rate. We then studied the effects of simultaneous engagement
of both LFA-1 and VLA-4 on T-lymphocyte migration under fluid flow. At low shear
rates, we observed directed migration either upstream or downstream that is dependent
upon the concentration of ICAM-1 and VCAM-1 present demonstrating synergy between
engagement of the LFA-1 and VLA-4 integrin receptors. In contrast, exposure to high
shear rates caused a switch in motility that favors LFA-1-mediated migration over VLA4-mediated migration with an overall preference for upstream migration. Through a shear
flow detachment assay, we suggest that LFA-1 interactions lead to stronger adhesions thus
providing the resistance for T-lymphocytes under fluid shear flow to support robust
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upstream migration. Furthermore, we show that the actin and tubulin cytoskeletons
undergo rearrangement upon the application of shear flow perhaps in order to increase the
cell tension required for migration under shear flow as well as to maintain structural
integrity. Together, these data suggests that the modes of T-lymphocyte motility are
governed not only by the presence of adhesive ligand but also their presentation and
activation in the presence of fluid flow. This provides new insight into the role of integrins
in mediating T-lymphocyte motility and understanding the critical role ligand composition
can play in controlling the physiological response of T-lymphocytes to shear flow.
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CHAPTER

5:

ADDITIONAL

LIGANDS

TO

STUDY

T-LYMPHOCYTE

HAPTOKINESIS AND CHEMOKINESIS
ABSTRACT
Homing to and migration within secondary lymphoid organs (SLOs) is not only
governed by the adhesive ligands ICAM-1 and VCAM-1 and the CCL19/CCL21/CCR7
chemokine axis. It is known that endothelial cells also express the chemokine CXCL12 on
their apical surface that binds to CXCR4 allowing for arrest and migration to extravasate
into inflamed tissues or the SLOs. Furthermore, fibronectin is known to be expressed by
fibroblastic reticular cells (FRCs) within SLOs and is a common ligand encountered by T
lymphocytes as well as other leukocytes. In this chapter we measured the migration of
primary human T lymphocytes in response to varying fibronectin concentration
(haptokinesis) and CXCL12 concentration (chemokinesis).

Through the use of

microcontact printing we created uniform surfaces of fibronectin of varying densities.
Furthermore, we exposed T lymphocytes to varying concentrations of soluble CXCL12 on
ICAM-1 surfaces. In the previous chapters, we demonstrated that exposing cells to varying
concentrations of ICAM-1 and VCAM-1 as well as CCL19 and CCL21 elicits biphasic
motility. In this chapter, we show that fibronectin elicits a monotonic response in motility
that leads to increases speeds and persistence times as ligand concentration increases.
Furthermore, CXCL12 elicits biphasic motility only on low concentrations of ICAM-1
similar to what is found with CCL19 and CCL21. Overall, motion on fibronectin is lower
than what was observed on ICAM-1 surfaces but similar to VCAM-1 further elucidating
motility observed within the SLOs.
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INTRODUCTION
We have demonstrated in the previous chapters that human primary T lymphocytes
are capable of spontaneous adhesion and robust migration on ICAM-1 and VCAM-1
microcontact printed PDMS surfaces. These ligands are known to be crucial for homing
and migration to and within the secondary lymphoid organs (SLOs) [1-4]. Here within the
organs, T lymphocytes are exposed to adhesive ligands and chemokines that facilitate the
interactions between T lymphocytes and dendritic cells [5-8]. This allows for the transfer
of information acquired by about foreign antigens by dendritic cells to T lymphocytes to
elicit effector functions. With this said, the cell adhesion molecules ICAM-1 and VCAM1 and the CCR7/CCL19/CCL21 chemokine signaling axis are not the only players involved
this process [9-12].
Fibronectin is a ubiquitous protein found both in a soluble plasma form, and in an
insoluble form that allows for cell adhesion and migration; both of these forms are from
the same gene undergoing alternative splicing patterns [13]. Fibronectin is a common
adhesive ligand used to study cell migration and motility.

Recent studies have

demonstrated that it support robust murine dendritic cell migration and can even elicit a
phenotypic switch in primary human neutrophils [14, 15]. We decided to study the motility
of human T lymphocytes in response to varying concentrations of fibronectin and compare
the findings to the motility observed on ICAM-1 and VCAM-1 substrates. Furthermore,
the chemokine CXCL12 binds to the chemokine receptor CXCR4 and is capable of
inducing chemotaxis [16, 17]. It is also involved in T lymphocyte homing to SLOs and in
numerous autoimmune diseases particularly those involved with the central nervous system
(CNS) [12]. We performed chemokinesis studies on ICAM-1 surfaces with varying
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concentrations of CXCL12 to determine if it elicits a biphasic response in motility similar
to what was observed with CCR7-mediated chemokinesis.

This response had been

previously observed in dendritic cells [14].
In this chapter, we investigate the effects on primary human T lymphocyte motility
by varying fibronectin concentrations (haptokinesis) and CXCL12 concentrations
(chemokinesis). We apply standard engineering approaches and the use of microcontact
printing to measure cell speed, persistence time, and the random motility coefficient on
these extracellular stimuli. Our results show that T lymphocytes elicit a monotonic
response in the random motility coefficient on varying fibronectin concentrations.
Furthermore, we demonstrate that T lymphocytes respond biphasically to the homeostatic
chemokine CXCL12 as function of ICAM-1 concentration similar to what was observed
for CCR7-mediated chemokinesis.
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MATERIALS AND METHODS
Cell culture and reagents
Human blood was obtained via venipuncture from healthy adult donors and
collected into sterile tubes containing sodium heparin (BD Biosciences). Samples were
collected with University of Pennsylvania Institutional Review Board approval from
consenting adult volunteers. Blood samples were carefully layered in a 1:1 ratio of whole
blood to 1-Step™ Polymorphprep (Axis-Shield). Vials were then centrifuged at 1500 rpm
for 35 minutes and the mononuclear band was collected into a fresh vial. Cells were
cultured in RPMI-1640 supplemented with 10% FBS and 1 μg/ml of phytohemagglutinin
(PHA-M; Sigma-Aldrich) overnight. After 24 hours, the lymphocyte suspension in the
PHA medium was transferred into a new flask leaving behind adherent cells. After an
additional 48 hours, the cells were then cultured in RPMI-1640 with 10% FBS and 1%
penicillin-streptomycin supplemented with 20 ng/ml of interleukin-2 (IL-2; Roche). Cells
were used for experimentation following an additional 72 hours in culture.

Other

biological reagents included: protein A/G (Thermo Scientific), human ICAM-1/Fc (R&D
Systems), human IgG1 (Abcam), human anti-beta2 (Calbiochem), , human anti-beta1 (BD
Pharmingen), human CXCL12 (PreproTech), and Pluronics F127 (Sigma-Aldrich).
Substrate preparation
Poly(dimethylsiloxane) (PDMS) (Dow Corning,) coated coverslips were prepared
from number one thickness glass coverslips (Fisher Scientific) of 25 mm diameter spin
coated with degassed PDMS (10:1 base:cure by weight) and cured overnight at 65 ºC.
PDMS-coated coverslips were affixed to the bottom of six-well tissue culture plates which
has been laser-cut to generate a 22 mm diameter opening in the bottom of the wells.
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Coverslip bonding was performed using a small amount of PDMS (10:1 base:cure by
weight) and baked at 65 ºC for 30 minutes for curing.
Protein printing and blocking
Flat stamps for printing were prepared by pouring degassed PDMS mixed at 10:1
base:cure by weight over an unpatterned silicon wafer. The polymer was cured for 2 hours
or longer at 65 ºC. Stamps were trimmed, sonicated in 200 proof ethanol for 10 minutes,
rinsed with dH2O, and dried in a stream of N2(g). For fibronectin haptokinesis studies,
stamps 1 cm2 were inked with 200 µl of varying concentrations of bovine fibronectin in
PBS for 2 hours at room temperature. For CXCL12 chemokinesis studies, stamps 1 cm 2
were inked with 200 µl of 2 µg/ml of protein A/G in PBS for 2 hours at room temperature.
The stamps were then thoroughly rinsed in H2O and blown dry with a stream of N2. In
parallel, the six-well PDMS coverslip substrate was treated with ultraviolet ozone for 7
minutes (UVO Cleaner Model 342) to render the surface hydrophilic. The stamps were
then placed in conformal contact with the substrate for ~10 seconds and removed. A 0.2%
(w/v) solution of Pluronics F127 was immediately adsorbed to the PDMS substrates for 30
minutes at room temperature to prevent protein adsorption to non-functionalized portions
of the PDMS. The cell culture substrate was then rinsed with PBS 3X without dewetting
the functionalized surface and either incubated with cells for fibronectin surfaces or
followed by deposition of 200 µl of ICAM-1/Fc in PBS for 2 hours at room temperature.
ICAM-1 functionalized surfaces were then rinsed with PBS 3X without dewetting before
incubation with cells.
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Haptokinesis and chemokinesis assay
PDMS substrates were prepared as described above. For printed CCL21 studies,
20 nM of CCL21 was inked with Protein A/G followed by stamping onto PDMS substrates.
Before use, all substrates were washed 3X with phosphate-buffered saline. Each well was
plated at 5 x 105 cells/ml in serum-free RPMI-1640 supplemented with 0.1% BSA and 2
mg/ml glucose. The substrate was then placed in a 37°C humidified atmosphere containing
5% CO2 in air incubator for 15 minutes to allow for cell attachment. The wells were then
gently washed 3X with PBS to remove non-adherent cells followed by imaging in a 5%
CO2 and 37°C environment for at least 1 hour. Cells were placed into a motorized stage
and observed using a Nikon Eclipse TE300 phase contrast microscope. A 10X objective
and 10X eyepiece were used for a final magnification of 100X. For chemokinesis assays,
a CCL19 and/or CCL21 chemokine solution was dispensed into each well before imaging
and performed on ICAM-1 substrates at a concentration of 0.05 µg/ml. For surface
presentation of CCL21, stamps were inked with 2 µg/ml of Protein A/G and 250 ng/ml of
CCL21 and printed onto the PDMS substrates before blocking and application of the Fc
protein solution.
Measurement of cell trajectories and mean-squared displacements
Cell movement was tracked using the ImageJ plugin Manual Tracking. ImageJ and
the plugin are both freely available through the NIH website (http://rsbweb.nih.gov/ij/).
The centroid of the cell was considered to represent the cell position. Time lapse
microscopy was used and images were taken every 1.5 minutes. The result was a series of
(x,y) positions with time for each cell. The net displacement during the 𝑖th 1.5 minute
increment, 𝐷𝑖 , was calculated by the difference of the position at the beginning and end of
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that time step. The mean-squared displacement, 〈𝐷2 (𝑡)〉, over time was calculated using
the method of non-overlapping intervals [18]. Speed, S, can be considered as the total path
length over time and persistence time, P, is the time a cell remains moving without
changing direction. S and P were obtained by fitting these to the persistent random walk
equation (Dunn, 1983 〈𝐷2 (𝑡)〉 = 2𝑆 2 [𝑡 − 𝑃(1 − 𝑒 −𝑡⁄𝑃 )] where t is the time interval, using
a non-linear least squares regression analysis [19, 20]. The mean-free path length (PL) and
random motility coefficient (µ) are then calculated as 𝑃𝐿 = 𝑃𝑆 and µ =

1
2

𝑆 2 𝑃 [21, 22].

Antibody Blocking
Functional blocking antibodies against the β1 integrin subunit (clone Mab13), β2
integrin subunit (clone IB4), αL integrin subunit (clone 38), and IgG2a isotype control
(clone R35-95) were used at a final concentration of 50 µg/ml. 5 x 105 T-lymphocytes in
500 µl of running buffer were incubated for 30 minutes with the blocking antibodies at
37ºC and 5% CO2. Cells were then plated and allowed to adhere for 15 minutes followed
by rinsing with PBS 3X and subsequent imaging in media containing blocking antibody.
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RESULTS AND DISCUSSION
Microcontact printing of fibronectin and T lymphocyte adhesion
Fibronectin is a common molecule that has been printed on PDMS surfaces to
support adhesion and motility of various cell types [15, 23, 24]. We use microcontact
printing to prepare surfaces of fibronectin of known concentrations as determined by initial
inking concentrations. The steps for microcontact printing for our experimental system are
illustrated in Figure 5.1A. Alexa Fluor-488 conjugated fibronectin was stamped onto a
PDMS surface to demonstrate precision of the method (Fig. 5.1B).
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A

B

Figure 5.1. µCP fibronectin on PDMS substrates. (A) Illustration for printing fibronectin
onto PDMS surfaces. (B) Alexa Fluor-488 conjugated fibronectin stamped onto a PDMS
surfaces. Scale bar = 50 µm (Image courtesy of Laurel Hind).
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Integrins containing the β1 subunit are known to bind to fibronectin surfaces
supporting adhesion and migration; we verified this through functional integrin blocking
and quantifying adhesion (Fig. 5.2A). Blocking of the β1 integrin chain resulted in a
significant decrease in cell adhesion on fibronectin relative to the positive control without
antibody present (p < 0.01) (Fig. 5.2B). These data led us to attribute the observed adhesion
and resulting motility to the specific ligation of β1 containing integrins binding to the
fibronectin printed surfaces.
Fibronectin alone triggers T lymphocyte haptokinesis
Primary human T lymphocytes adhere and migrate on PDMS surfaces printed with
fibronectin. We measured haptokinesis on fibronectin by quantifying the mean-squared
displacements over a range of ligand concentration in the absence of chemokine. From the
mean-squared displacements over time, we could determine the speed, persistence time,
and random motility coefficient for each ligand concentration. T lymphocytes plated on
fibronectin surfaces were tracked for 30 minutes. As illustrated by representative singlecell migration tracks (Fig. 5.3), T lymphocytes migrated substantial distances on both 0.5
and 5.0 µg/ml of fibronectin with no preferred direction. This remained true for all other
concentrations of ligand tested.
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A

B

Figure 5.2. Antibody blocking against β1 reveals discrete integrin/ligand interactions on
printed fibronectin surfaces. (A) Phase contrast images of T lymphocytes blocked against
β1or β2 integrins on fibronectin surfaces. (B) Quantification of antibody blocking against
β1 and β2 integrins show decreased cell adhesion to fibronectin substrates; *p < 0.05,
compared to isotype; one-sample t test.
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Figure 5.3. T lymphocyte cell traces on fibronectin surfaces. Representative single-cell
migration tracks for T lymphocytes on 1.0, 10.0, 50.0, and 100.0 µg/ml of fibronectin
showing no preferred direction in migration (haptokinesis).
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Using the mean-squared displacements (MSD), we found that migrating T
lymphocytes on fibronectin surfaces migrated substantial distances as observed by the
linear increase of the mean-squared displacement over time (Fig. 5.4, A and B). As with
LFA-1- and VLA-4-mediated motility, the use of random walk theories is common to
quantify this migration. The MSDs of migration can be scaled as x 2(t) ∝ tα during 0 < t <
30 minutes where fitting can be used to determine the exponent α to classify the type of
motion for each type and concentration of ligand. Random or Brownian motion is observed
for the value of α = 1 and ballistic motion is observed for α = 2, while values between the
two are categorized as superdiffusive motion. Cells migrating on fibronectin surfaces
display an average α over all concentrations of 1.40, indicating superdiffusive motility.
This value is lower than what was found on ICAM-1 surfaces (α = 1.57) but similar to
values observed on VCAM-1 surfaces (α = 1.38). Table 3.1 shows all values of fitted α’s
for all concentrations of ligand tested. With this said, this data is consistent with data
presented in previous chapters that T lymphocytes do not display pure diffusive motion on
ICAM-1 or VCAM-1 printed substrates. Furthermore, recently we have shown that
neutrophils migrate superdiffusively with a keratocye-like phenotype on fibronectin
printed substrates indicating similarities between possible migration mechanisms for these
two types of leukocytes [15].
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Figure 5.4. Mean-squared displacements versus time of migrating human T-lymphocytes
on varying fibronectin concentrations.

Table 5.1. Average fitted α ± standard deviation on fibronectin. Values of fitted α’s
indicate superdiffusive for almost all concentration conditions on fibronectin surfaces.
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By scaling the mean squared displacements to tα and plotting them as slopes over
time, we see that all T lymphocyte motility lies between a slope of 1 (pure diffusion motion)
and a slope of 2 (pure ballistic motion) lying in the superdiffusive region on all three ligands
(Fig. 5.5). We also show that the superdiffusive motility exist in three different regimes
for the three ligands. T lymphocytes exhibit more diffusive-like motion on VCAM-1
surfaces compared to ICAM-1 surfaces with cell exhibiting more ballistic-like motion on
fibronectin surfaces. This is the first indication, to our knowledge, that T lymphocytes
exhibit superdiffusive motion on these ligands.
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Figure 5.5. Fitted mean-squared displacements versus time on ICAM-1, VCAM-1, and
fibronectin surfaces. The slopes of lines indicate the α’s determined by scaling the MSD
previously to tα. Red lines are values on ICAM-1 surfaces, blue lines are values on VCAM1, and green lines are on fibronectin surfaces. Slopes of the lines fall between values of 1
(pure diffusive motion) and 2 (pure ballistic motion).
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To further characterize the motility of T cells on ICAM-1 and VCAM-1 surfaces,
we used the experimental mean-squared displacements of each cell population with the
persistent random walk model to fit for speed and persistence time.

Migrating T

lymphocytes average cell speeds (S) ranging between 1.55 ± 0.69 and 5.5 ± 0.78 µm/min
with peak speed reached on 50.0 µg/ml of fibronectin (Fig. 5.6). These speeds were much
lower than what was observed on ICAM-1 surfaces but similar to those observed on
VCAM-1 (whose integrin contains the β1 subunit). Persistence times (P) ranged from 1.25
± 0.9 to 12.0 ± 1.5 minutes; these were much larger values that what was found on the
previous two adhesion molecules.
Overall, both responses for speed and persistence time as a function of fibronectin
concentration were found to be monotonic. This behavior has been observed previously
on fibronectin using murine myoblasts and could be due to differences in bond strength,
production of signals required for force generation, or organization of the receptors by the
cytoskeleton [25, 26]. Furthermore, it is also known that fibronectin can be engaged
through multiple integrin receptors: α4β1 (VLA-4) binds the CS-1 sequence and α5β1 (VLA5) binds the RGD sequence; both are expressed on T-lymphocytes [27, 28]. Engagement
of these receptors may lead to different downstream signaling and/or different binding of
adaptor proteins leading to different responses in motility. This sort of behavior has been
observed in murine epithelial cells where α5β1 and αvβ3 both bind to fibronectin resulting
in the same level of adhesion but differ in cellular morphology and motility [29].
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Figure 5.6. T lymphocytes elicit monotonic responses in speed and persistence time on
fibronectin surfaces. T lymphocyte (A) speeds and (B) persistence times determined from
using the persistent random walk model; cells have faster speeds and longer persistence
times as ligand concentration increases.

167

As with motility on ICAM-1 and VCAM-1 surfaces, we calculated the random
motility coefficient (µ). Figure 5.7 demonstrates that the random motility coefficient
increases with increasing concentration of fibronectin reaching a maximum value of 141.85
± 16.45 µm2/min (µFibro) on 10.0 µg/ml.

Figure 5.7. Fibronectin elicits a monotonic response in the random motility coefficient on
fibronectin surfaces. Comparison of the random motility coefficients (µ) show a
monotonic response in motility as a function of ligand concentration (peak µFibro = 141.85
± 16.45 µm2/min). The error bars represent the standard error of the mean (s.e.m.)
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Comparing the values of the random motility coefficient to our previous surfaces
of ICAM-1 and VCAM-1, we observe distinct differences (Fig. 5.8). On ICAM-1, the
highest random motility coefficient (µICAM-1) is 160 µm2/min, observed over a range of
ICAM-1 concentrations between 0.5 to 10.0 µg/ml. T lymphocytes display a maximum
µVCAM-1 of 103 ± 16.1 µm2/min at 0.5 µg/ml VCAM-1. Overall, we generally found that
cells exhibit greater motility on ICAM-1 followed by fibronectin and then VCAM-1
(µICAM-1 > µFibro > µVCAM-1).
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Figure 5.8. The random motility coefficients for all ligand concentrations on ICAM-1,
VCAM-1, and fibronectin surfaces. Comparison of the random motility coefficients (µ)
show biphasic motility as a function of ligand concentration with ICAM-1 (peak µICAM-1 =
2

172.77 ± 45.45 µm /min) promoting increased haptokinesis than VCAM-1 (peak µVCAM-1
2

= 103.58 ± 16.06 µm /min) with a monotonic response on fibronectin surfaces (peak µFibro
= 141.85 ± 16.45 µm2/min). The error bars represent the standard error of the mean (s.e.m.)
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In our system, higher cell speeds were observed on ICAM-1 compared to VCAM1 and fibronectin (SICAM-1 > SVCAM-1/SFibro) while generally cells were more persistent on
fibronectin and VCAM-1 than ICAM-1 (PICAM-1 < PVCAM-1 < PFibro). Previous empirical
observations have showed that speed and persistence times are inversely correlated across
a variety of cells types with high speeds correlating to short persistence times and vice
versa [26].

Previously, we plotting the speeds and persistence times across all

concentrations of ICAM-1 and VCAM-1 and observed that this inverse correlation holds
true for primary human T lymphocytes. On fibronectin surfaces, this inverse correlation
does not hold since as speeds increase, persistence times increase as well (Fig. 5.9).
Overall, on ICAM-1 surfaces, T- lymphocytes have higher speeds with lower persistence
times (↑ SICAM-1, ↓ PICAM-1) and on VCAM-1 surfaces, T lymphocytes have lower speeds
with higher persistence times (↓ SVCAM-1, ↑ PVCAM-1). For cells on fibronectin, you have
similar speeds to that on VCAM-1 but with much higher persistence times that trend
together (↓ SFibro, ↑↑ PFibro). These data suggests that each ligand stimulates different
adhesion signaling pathways through engagement of different integrin adhesion receptors.
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Figure 5.9. T lymphocytes elicit biphasic responses in speed and an inverse correlation
with persistence time on ICAM-1 and VCAM-1 but not on fibronectin. T lymphocyte (A)
speeds and (B) persistence times determined from using the persistent random walk model;
cells have faster speeds and shorter persistence times on ICAM-1 with lower speeds and
longer persistence times on VCAM-1 while cells on fibronectin elicit a monotonic
response. (C) Across all concentrations of ligand an inverse correlation is maintained
between persistence time and cell speed on ICAM-1 and VCAM-1 but not on fibronectin.
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CXCL12 induces T lymphocyte chemokinesis that is dependent on ICAM-1
concentration
The chemokine CXCL12 binds to the CXCR4 receptor and is capable of driving
chemokinesis and chemotaxis [11, 14]. As with previous CCL19 and CCL21 studies,
transwell assays have predominantly been used to demonstrate chemokinesis and
chemotaxis, but these three dimensional assays provided limited ability to directly observe
cells [30-32]. We decided to investigate CXCL12 mediated chemokinesis on ICAM-1
surfaces to see if we can see a peak in the random motility coefficient as a result of CXCR4
signaling. We designated ICAM-1 concentrations of 5.0 µg/ml as high and 0.05 µg/ml as
low; these two concentrations support spontaneous and robust T lymphocyte migration, as
shown in Chapter 3 of this thesis. We measured the random motility coefficient for a range
of CXCL12 chemokine concentrations on both high and low concentrations of ICAM-1.
We observed no significant differences in the random motility coefficients as a function of
chemokine concentration on the high ICAM-1 surface with random motility coefficients
(µHIGH) ranging between 208 ± 32.2 to 262 ± 52.5 µm2/min (Fig. 3.10). We have showed
that T lymphocytes are capable of sustained motility on ICAM-1 alone without the need
for chemokines; this leads us to believe that sustained signaling through LFA-1/ICAM-1
interactions at this high ligand concentration was overwhelming the signals that resulted
from CXCR4 receptor engagement similar to what was observed for CCR7 mediated
chemokinesis. On the low ICAM-1 surface, we observed a biphasic response in motility
to chemokine concentrations.

Statistically significant peaks in the random motility

coefficients (µLOW) were observed at 100 nM for CXCL12 (43.44 ± 4.82 µm2/min) when
compared to the random motility coefficient observed on low ICAM-1 alone (p < 0.05; Fig.
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5.10). The values of the random motility coefficients for CXCL12 chemokinesis on low
ICAM-1 surfaces are much less than what was observed for CCR7-mediated chemokinesis.
Empirical observations in other cell systems have estimated the KD of the CXCR4 receptor
to be between 3 - 15 nM with observable peaks in motility which is significantly far less
than what we show for the peak in the random motility coefficient [33, 34]. The observed
peak of motility here with CXCR4 mediated chemokines may be a unique characteristic of
T lymphocytes in our experimental system.

Figure. 5.10. sCXCL12 induces chemokinesis on low ICAM-1 surfaces. Comparison of
the random motility coefficients (µ) show biphasic responses on low but not high ICAM-1
surfaces. Peak in chemokinesis observed at 100 nM with a value of 43.44 μm2/min; *p <
0.05, compared to all concentrations; one-sample t test.
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CONCLUSIONS
In this chapter, we measured the migration of primary human T lymphocytes on
microcontact printed fibronectin PDMS surfaces and the effect of CXCL12 on ICAM-1.
Our results show that T lymphocytes are capable of spontaneous and robust adhesion and
migration to fibronectin in the absence of chemokine.

By varying the fibronectin

concentrations, we are able to modulate the speed, persistence times, and thus their random
motility on these surfaces. As seen with LFA-1- and VLA-4-mediated motility, their
motion is non-Brownian with superdiffusive behavior similar to what is seen on VCAM-1
surfaces. Unlike their motion on ICAM-1 and VCAM-1 surfaces, their motion is not
biphasic on fibronectin surfaces but rather monotonic with both speed and persistence time
increasing with ligand concentration. This leads us to believe that signaling through
engagement of the three different integrins results in different modes of motility. Overall,
we conclude through haptokinesis studies that ICAM-1 contributes more to motility than
either VCAM-1 or fibronectin.
Furthermore, we explore chemokinesis to CXCL12 on ICAM-1 surfaces. As seen
with CCL19 and CCL21, this response is dependent upon ligand concentration with T
lymphocytes eliciting biphasic motility as a function of chemokine concentration on low
ICAM-1 surfaces. We observe a peak in the random motility coefficient at a concentration
of chemokine that is far greater than what has been observed before implying, perhaps, a
unique response CXCL12-mediated chemokinesis in T lymphocytes.

175

REFERENCES
1.

Springer, T.A., Traffic signals for lymphocyte recirculation and leukocyte
emigration: the multistep paradigm. Cell, 1994. 76(2): p. 301-14.

2.

Butcher, E.C. and L.J. Picker, Lymphocyte homing and homeostasis. Science, 1996.
272(5258): p. 60-6.

3.

von Andrian, U.H. and C.R. Mackay, T-cell Function and Migration: Two Sides of
the Same Coin. N Engl J Med, 2000. 343(14): p. 1020-34.

4.

Rose, D.M., J. Han, and M.H. Ginsberg, Alpha4 integrins and the Immune
Response. Immunol Rev, 2002. 186: p. 118-24.

5.

Cahalan, M.D. and I. Parker, Choreography of cell motility and interaction
dynamics imaged by two-photon microscopy in lymphoid organs. Annu Rev
Immunol, 2008. 26: p. 585-626.

6.

Miller, M.J., et al., T cell repertoire scanning is promoted by dynamic dendritic cell
behavior and random T cell motility in the lymph node. Proceedings of the National
Academy of Sciences of the United States of America, 2004. 101(4): p. 998-1003.

7.

Bousso, P. and E.A. Robey, Dynamic Behavior of T Cells and Thymocytes in
Lymphoid Organs as Revealed by Two-Photon Microscopy. Immunity, 2004. 21(3):
p. 349-355.

8.

Bajenoff, M., et al., Stromal cell networks regulate lymphocyte entry, migration,
and territoriality in lymph nodes. Immunity, 2006. 25(6): p. 989-1001.

9.

Miller, M.J., et al., Two-Photon Imaging of Lymphocyte Motility and Antigen
Response in Intact Lymph Node. Science, 2002. 296(5574): p. 1869-1873.

176

10.

Sobocinski, G.P., et al., Ultrastructural localization of extracellular matrix
proteins of the lymph node cortex: evidence supporting the reticular network as a
pathway for lymphocyte migration. BMC Immunol, 2010. 11: p. 42.

11.

Shahabi, N.A., K. McAllen, and B.M. Sharp, Stromal cell-derived factor 1-alpha
(SDF)-induced human T cell chemotaxis becomes phosphoinositide 3-kinase
(PI3K)-independent: role of PKC-theta. J Leukoc Biol, 2008. 83(3): p. 663-71.

12.

Karin, N., The multiple faces of CXCL12 (SDF-1alpha) in the regulation of
immunity during health and disease. J Leukoc Biol, 2010. 88(3): p. 463-73.

13.

Mao, Y. and J.E. Schwarzbauer, Fibronectin fibrillogenesis, a cell-mediated matrix
assembly process. Matrix Biol, 2005. 24(6): p. 389-99.

14.

Ricart, B.G., et al., Dendritic cells distinguish individual chemokine signals
through CCR7 and CXCR4. J Immunol, 2011. 186(1): p. 53-61.

15.

Henry, S.J., J.C. Crocker, and D.A. Hammer, Ligand density elicits a phenotypic
switch in human neutrophils. Integrative Biology, 2014. 6(3): p. 348-356.

16.

Cherla, R.P. and R.K. Ganju, Stromal cell-derived factor 1 alpha-induced
chemotaxis in T cells is mediated by nitric oxide signaling pathways. J Immunol,
2001. 166(5): p. 3067-74.

17.

Cyster, J.G., Chemokines and Cell Migration in Secondary Lymphoid Organs.
Science, 1999. 286(5447): p. 2098-2102.

18.

Dickinson, R.B. and R.T. Tranquillo, A stochastic model for adhesion-mediated
cell random motility and haptotaxis. Journal of Mathematical Biology, 1993. 31(6):
p. 7.

177

19.

Othmer, H.G., S.R. Dunbar, and W. Alt, Models of dispersal in biological systems.
Journal of Mathematical Biology, 1988. 26(3): p. 263.

20.

Dunn, G.A., Characterising a kinesis response: time averaged measures of cell
speed and directional persistence. Agents and Actions Supplements, 1983. 12: p.
19.

21.

Stokes, C.L., D.A. Lauffenburger, and S.K. Williams, Migration of individual
microvessel endothelial cells: stochastic model and parameter measurement. J Cell
Sci, 1991. 99 ( Pt 2): p. 419-30.

22.

Ford, R.M. and D.A. Lauffenburger, Measurement of bacterial random motility and
chemotaxis coefficients: II. Application of single-cell-based mathematical model.
Biotechnology and Bioengineering, 1991. 37(7): p. 661-672.

23.

Desai, R.A., et al., Subcellular spatial segregation of integrin subtypes by patterned
multicomponent surfaces. Integr Biol (Camb), 2011. 3(5): p. 560-7.

24.

Rodriguez, N.M., et al., Micropatterned Multicolor Dynamically Adhesive
Substrates to Control Cell Adhesion and Multicellular Organization. Langmuir,
2014. 30(5): p. 1327-1335.

25.

Goodman, S.L., G. Risse, and K. von der Mark, The E8 subfragment of laminin
promotes locomotion of myoblasts over extracellular matrix. J Cell Biol, 1989.
109(2): p. 799-809.

26.

Lauffenburger, D.A. and J.J. Linderman, Receptors: Modeling for Binding,
Trafficking, and Signaling. 1996, New York: Oxford University Press.

178

27.

Laffon, A., et al., Upregulated expression and function of VLA-4 fibronectin
receptors on human activated T cells in rheumatoid arthritis. J Clin Invest, 1991.
88(2): p. 546-52.

28.

Rodriguez, R.M., et al., T lymphocyte adhesion to fibronectin (FN): a possible
mechanism for T cell accumulation in the rheumatoid joint. Clin Exp Immunol,
1992. 89(3): p. 439-45.

29.

Truong, H. and E.H. Danen, Integrin switching modulates adhesion dynamics and
cell migration. Cell Adh Migr, 2009. 3(2): p. 179-81.

30.

Yoshida, R., et al., EBI1-ligand chemokine (ELC) attracts a broad spectrum of
lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate
toward ELC. International Immunology, 1998. 10(7): p. 901-910.

31.

Frow, E.K., J. Reckless, and D.J. Grainger, Tools for anti-inflammatory drug
design: In vitro models of leukocyte migration. Medicinal Research Reviews, 2004.
24(3): p. 276-298.

32.

Campbell, J.J., et al., 6-C-kine (SLC), a Lymphocyte Adhesion-triggering
Chemokine Expressed by High Endothelium, Is an Agonist for the MIP-3β Receptor
CCR7. The Journal of Cell Biology, 1998. 141(4): p. 1053-1059.

33.

Oberlin, E., et al., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and
prevents infection by T-cell-line-adapted HIV-1. Nature, 1996. 382(6594): p. 8335.

34.

Laguri, C., et al., The novel CXCL12gamma isoform encodes an unstructured
cationic domain which regulates bioactivity and interaction with both

179

glycosaminoglycans and CXCR4. PLoS One, 2007. 2(10): p. e1110.

180

CHAPTER 6: CONCLUSIONS AND FUTURE WORK
SPECIFIC AIMS
The research presented in this work shows that we were able to successfully
characterize primary human T lymphocyte motility in response to three different adhesion
ligands (haptokinesis), three different chemokines (chemokinesis), and fluid shear flow
(mechanotaxis) on microcontact printed PDMS substrates.
Aim 1a: Characterize the motility of primary human T-lymphocytes on microcontact
printed PDMS surfaces.
Aim 1b: Characterize the chemokinetic behavior of primary human T-lymphocytes in
response to the homeostatic chemokines CCL19 and CCL21.
Aim 2: Quantify the motility of primary human T-lymphocytes on ICAM-1, VCAM-1 and
combined ICAM-1/VCAM-1 PDMS surfaces under shear flow.
SPECIFIC FINDINGS
T Lymphocyte haptokinesis on ICAM-1, VCAM-1, and fibronectin substrates
We have investigated the effects of ligand concentration on T lymphocyte motility
through quantification of the speeds, persistence times, and random motility coefficients.
Through the use of microcontact printing, we printed PDMS spin coated glass coverslips
with either protein A/G for Fc-containing ligands or fibronectin. All ligands were capable
of supporting spontaneous adhesion and robust migration in the absence of chemokine.
The use of ICAM-1/Fc and VCAM-1/Fc allows for quantification of motility elicited by
engagement of their sole integrin binding partner LFA-1 (αLβ2) and VLA-4 (α4β1),
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respectively [1]. The observed motility on these substrates was biphasic with peaks in the
random motility coefficients that is dependent upon ligand concentration. Furthermore, T
lymphocytes maintained an inverse relationship between speed and persistence time that is
typically seen in other cell types (Fig. 6.1) [2]. When cells were plated on varying
concentrations of fibronectin, cells displayed a monotonic response with increasing speeds
and persistence times with increasing ligand concentrations. Observed speeds for cells on
fibronectin were similar to those quantified on VCAM-1 substrates; these similarities may
lie in the fact that the engaged integrins are both β1 containing. We also determined that T
lymphocytes exhibit superdiffusive motion on these substrates which has recently been
observed in vivo and in human neutrophils [3, 4]. Overall, T lymphocytes are more active
on ICAM-1 than VCAM-1 or fibronectin surfaces, and ligand composition and
concentration are essential in controlling their motility. Understanding how the three
ligands affect T lymphocyte motility can provide insight into migration to and within
secondary lymphoid organs (SLOs).
Quantifying chemokinesis using the homeostatic chemokines CCL19, CCL21, and
CXCL12
Along with varying ligand composition, T lymphocytes are exposed to various
chemokines that are required for migration and entry to SLOs [5, 6]. These homeostatic
chemokines are known as CCR7-binding CCL19 and CCL21 and CXCR4-binding
CXCL12. Initially, T lymphocytes were exposed to uniform concentrations of chemokine
on ICAM-1 surfaces. There was no observable peak in motility leading us to conclude that
the ligand concentration was too high thus preventing a response to chemokine. After
repeating the experiments with a concentration that was two orders of magnitude lower, T
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lymphocytes exhibited biphasic responses in the random motility coefficient to CCL19,
CCL21, and CXCL12. The peak in the random motility coefficient corresponds to the KD
of each receptor [7]. CCR7 has a peak around 20 nM which is similar to what is found in
literature [8, 9]. CXCR4, on the other hand, had a peak around 100 nM – a value that has
not been previously observed.
Along the blood endothelium and within the SLOs, CCL19 and CCL21 are known
to work together to drive homing and migration through simultaneous engagement of the
CCR7 receptor [10]. This led us to ask whether combined chemokinesis of CCL19 and
CCL21 would synergize and increase motility further. By combining both in solution, T
lymphocyte motility was increased to levels above what was observed by each chemokine
individually. However within the body, CCL21 is expressed on the blood endothelium and
presented to cells on the surface rather than in soluble form [11, 12]. This led us to create
surfaces of printed CCL21 with ICAM-1 and repeat the chemokinesis assay with varying
concentrations of soluble CCL19. This resulted in T lymphocytes exhibiting random
motility greater than what was observed by exposing to both soluble chemokines,
combined or individually. Here, we demonstrated that CCL19 and CCL21 were capable
of enhancing the motion of T lymphocytes and that enhancement was dependent upon the
presence of an adhesive ligand.
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T Lymphocyte migration under shear flow is dependent upon the presentation of
ICAM-1 and VCAM-1
During T lymphocyte homing, cells must adhere and migrate along the blood
endothelium to undergo diapedesis into the site of inflammation or SLO [13, 14]. These
steps are mediated through the integrins LFA-1 and VLA-4. Previously, it was shown that
demonstrated that naïve and effector T lymphocytes orient their migration against the
direction of flow on ICAM-1 surfaces [15]. This effect was shown to be dependent upon
shear rate with higher shear leading to an increased bias in upstream migration. We decided
to investigate this further by quantifying T lymphocyte migration on ICAM-1 and VCAM1 surfaces alone and on combinations of the two under varying shear rates. For T
lymphocytes on ICAM-1 surfaces, upstream migration was found to not be dependent upon
ligand concentration but rather shear rate with increasing shear rate resulting in an increase
in preferred migration direction. For cells on VCAM-1, migration was downstream with
fluid flow and found to be dependent upon ligand concentration and, to a lesser extent,
shear rate.
Since extravasation requires LFA-1 and VLA-4 for transient and firm adhesion and
migration, we created surfaces that present varying densities of the ligands ICAM-1 and
VCAM-1 [16, 17]. For cells exposed to low shear rates, the resulting migration showed
varying preferences either upstream or downstream of fluid flow that appeared to be
dependent upon the densities of the ligand used. Upon exposure to high shear flow, a
switch in migration was observed with cells orienting their migration upstream of fluid
flow indicating a possible preference in utilizing LFA-1-ICAM-1 interactions to drive
motility. This was further supported upon qualitative assessment of adhesion strength
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mediated through LFA-1, VLA-4, or LFA-1/VLA-4 engagements.

Increased shear

resistance was observed on ICAM-1 containing surfaces when compared to VCAM-1.
Furthermore, it is known that VLA-4 engagement can regulate β2-mediated adhesion, and
our data further indicates synergy of these two integrins to facilitate migration under shear
on two-dimensional substrata [18, 19].
FUTURE WORK
Shear sensing: what is the intracellular signal?
Our flow chamber work has shown that T lymphocytes respond to shear in a ligand
and shear rate specific manner. We ask the question – what is allowing the cell to sense
this mechanical stress? There has been some exploration into what signaling molecules
permit cell adhesion under flow but not specifically what controls the migration. We have
performed some preliminary experiments using small molecule inhibitors against known
signaling molecules involved in cell motility and adhesion; the molecules targeted include
actin (Cytochalasin D), myosin II (blebbistatin), ROCK (Y-27632), PI3K (LY294002), and
Rac (NSC23766).

These molecules are known to be compartmentalized within T

lymphocytes with ROCK and myosin II being concentrated at the rear of the cell and
required for actomyosin contractility [20, 21]. Rac and PI3K are known to be in the front
of the cell with Rac being required for stable actin polymerization while PI3K has been
implicated in the sensing of the chemical gradients [22-24]. Upon disruption of actin
filaments using Cytochalasin D, no cells adhered to the surface and thus no quantification
of motility was permitted (data not shown). Figure 6.1 shows that all the inhibitors caused
decreased upstream migration under 100 s-1 but increased upstream migration on 800 s-1.
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Furthermore, migration speeds were also not what we expected with increased speeds for
some inhibitors under 100 s-1 compared to static (Fig. 6.2). These data is inconclusive and
indicates that another signaling pathway is most likely involved in shear sensing leading to
directional migration upstream of fluid flow. It would also be advantageous to do
fluorescent labeling of candidate molecules or western blots to measure their distribution
and amount.
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Figure 6.1. Effect of pharmacological inhibitors on the orientation of T-lymphocyte
migration under shear flow. The effect of pharmacological inhibitors on the migration
index for static, low, and high shear conditions.
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Figure 6.2. Effect of pharmacological inhibitors on the speed of T-lymphocyte migration
under shear flow. The effect of pharmacological inhibitors on the speed for static, low,
and high shear conditions.
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Another possible target for inhibition in determining the mechanosensing in T
lymphocytes is Vav1. Evidence has shown that Vav1, a guanine exchange factor (GEF)
for the Rho family GTPases Rac and Cdc42, is involved in mechanosensing in murine
neutrophils under shear flow. In Vav1 deficient murine neutrophils, cells lost the ability
to migrate perpendicular to fluid flow [25]. A known Rac inhibitor, 6-Thio-GTP, is known
to block the activity between Vav1 and Rac and could prove useful to study Vav1’s
involvement in migration under shear flow. The previously used Rac inhibitor NSC23766
blocks the activity between Rac and another GEF known as Tiam1 which is know to be
involved in other processes [26-28].
Geometric patterning substrates for migration
It is well known that ligand geometry affects cell behavior [29, 30]. We would like
to quantify the effects of ligand geometry on T lymphocyte migration in the absence and
presence of shear flow on ICAM-1, VCAM-1, and fibronectin surfaces. Through the use
of microcontact printing and the “stamp-off” method, we can create patterned lined
substrates of varying widths ranging from 3 to 25 µm and larger (Fig. 6.3) [31-33].
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Figure 6.3. Patterned substrates of protein A/G with varying line widths. Surfaces were
prepared using the stamp-off method with Alex Fluor-555 conjugated Protein A/G.
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Preliminary experiments show that T lymphocytes plated on these substrates
exposed to 100 s-1 of fluid flow display a bias in migration depending upon line orientation
– either orthogonal or parallel to fluid flow (Fig. 6.4).

Figure 6.4. Traces of cell migration paths on patterned substrates of ICAM-1. T
lymphocytes were allowed to crawl under 100 s-1 on ICAM-1 lined substrates.
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Use of the stamp off method for microcontact printing allows for surface
functionalization with multiple ligands. Cells have been shown to respond differently to
patterned substrates with multiple ligands [32]. This technique would prove useful to study
the effects of exposing T lymphocytes to ligand in alternating patterns. In this thesis, we
have discussed that T lymphocytes migrate differently in response to various ligands; we
would thus like to quantify this migration on spatially segregated ligands. Figure 6.5 shows
that we can create alternating patterns of Alexa Fluor-488 conjugated fibronectin and Alexa
Fluor-555 conjugated protein A/G at the smallest resolution of lines available (3 µm X 3
µm). Dual presentation of ligands in an ordered geometric pattern would provide further
insight into how cell adhesion molecules control T lymphocyte migration under static
conditions and under shear flow.

Figure 6.5. Alternating lines of fibronectin and protein A/G. 3 µm x 3 µm lines of
alternating fibronectin (green) and protein A/G (red). Scale bar = 25 µm @ 40X
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Haptokinesis on combined surfaces of ICAM-1 and VCAM-1 and LifeAct GFP
transfection
Finally, we would like to expand upon our work of combined ligand surfaces of
both ICAM-1 and VCAM-1. By repeating the experiments under static conditions, we
could explore the signaling dynamics that occur upon engagement of both ligands allowing
us to have increased insight about their migration under fluid flow. By performing western
blots, we could identify the level of integrin activation downstream of receptor engagement
as a function of ligand concentration for all combinations of ICAM-1 + VCAM-1.
Furthermore, we would like to virally transduce cells to express the LifeAct-GFP construct
for actin visualization. We believe this would allow us to better characterize the migration
of T lymphocytes on ICAM-1 and VCAM-1 under fluid flow.
FINAL THOUGHTS
Homing and migration of leukocytes is at the heart of the immune system.
Specifically, T lymphocytes are required to adhere and migrate on adhesive ligands,
respond to chemokines, and withstand the hemodynamic forces present in order for them
to reach sites of inflammation and lymphoid tissue. While we only focused on a specific
aspect of controlling T lymphocyte migration, we believe this work contributes to the field
of immunology and cell migration. Through our work, we have gained further insight into
the dynamics of T lymphocyte motility on three different physiological ligands, how
homeostatic chemokines govern their motility, and the effects that shear flow has on their
ability to adhere and migrate. We hope this work will continue on engineered substrates
to control migration and inspire future ideas and projects.
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